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 1 
CHAPTER I 
 
INTRODUCTION 
 
Bves (blood vessel epicardial substance) was initially described in the 
literature eight years ago (Reese et al. 1999).  Despite the existence of nearly 20 
publications investigating this gene, very little has been learned about the 
functional significance of this protein.  Several phenotypic abnormalities have 
been generated via alteration of bves expression levels, yet little evidence exists 
to substantiate a molecular mechanism underlying these phenotypes.  Of course, 
determination of the function of a novel protein is a very attractive goal for those 
interested in basic science, and was the topic that I selected for my doctoral 
research. 
 This introductory chapter will provide a synopsis of the existing literature 
concerning Bves.  Additionally, a brief review of Rho-family GTPase signaling is 
also provided, which will be helpful in understanding the potential functional 
implications of the work described in this doctoral thesis.    
 
Bves:  Discovery and initial characterization 
To identify novel genes expressed during heart development, we 
performed a subtractive hybridization screen in the HH stage 18 chicken heart 
(Reese et al. 1999). bves (blood vessel epicardial substance) is a novel 
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message identified through this screen, as reported by Reese et al. (1999). We 
assigned the name Bves to the protein product because our first antiserum 
recognized the protein in cells of the epicardium and developing coronary 
vascular system. Using a similar screen, Thomas Brand and colleagues 
independently identified an identical chick cDNA, which they termed “pop1a”, and 
characterized a related family of genes in chick and several other species 
(Andree et al. 2000). As these transcripts were identified in heart and skeletal 
muscle, they assigned the name popeye to the gene family to reflect the robust 
expression pattern in muscle types. The Duncan laboratory also independently 
identified Bves in a screen for genes transcriptionally-regulated in eye 
development (M. Duncan, personal communication) and later reported the 
characterization of two monoclonal antibodies directed against the protein 
(DiAngelo et al. 2001).  For clarification, the correct nomenclature in mouse and 
human for the bves/pop1a gene and protein is Bves. The accepted names for the 
protein products of family members popdc2 and popdc3 are Popdc2 and Popdc3, 
respectively  (Mouse Genome Informatics, Jackson Labs; HUGO Gene 
Nomenclature Committee).  The gene family is known as the popdc (popeye 
domain-containing) family. 
Since the initial identification of bves in chicken, mouse and human, 
cDNAs representing this gene have been reported in all classes of vertebrates. 
Homologous Bves sequences have been identified in several invertebrates, 
including insects Drosophila and Anopheles, through a search for EST clones 
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with internet-based search engines (NCBI, Ensembl). Additionally, related 
transcripts have been reported in the cephalochordate Amphioxus floridae 
(Andree et al. 2000), as well as Ciona intestinalis (Davidson and Levine 2003) 
and the ascidian Boltenia villosa (Davidson et al. 2003). To date, Bves has not 
been reported to be in the C. elegans genome, in any single cell organism, or in 
plant species.  
The genomic location and structure of Bves is known for several species 
(Table 1). Mouse Bves lies on chromosome 10, human Bves has been mapped 
to chromosome 6q21, and the chicken gene is located on chromosome 3. The 
cloning of bves in many organisms has allowed a cross-species comparison of 
gene structure, which varies considerably. The mouse gene consists of 11 exons, 
while human BVES has only five exons. The chicken and Drosophila bves genes 
have eight and seven exons, respectively.  Chicken bves generates a message 
of approximately 1.7kb, while mouse bves is 1.8kb (Reese et al. 1999; Andree et 
al. 2000). A high sequence similarity exists at the nucleotide level (>70%). In 
addition, the presence of at least four individual transcripts from the chicken bves 
gene has been demonstrated, and originally reported as Pop1A-Pop1D (Andree 
et al. 2000). The splice variants appear to be generated principally in the extreme 
5’ and 3’ ends of the coding region (Andree et al. 2000). To date, no insight 
concerning function has been derived from the genomic structure. Currently, 
none of the promoter or enhancer elements that drive cell-specific expression 
have been described for bves or any other popdc genes, although bves has been  
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identified as a target of Pax3, a key developmental transcription factor in muscle 
(Barber et al. 2002). 
This dissertation will focus primarily on the bves gene and its gene 
product, Bves. However, it is necessary and appropriate to point out similarities 
and differences between the other family members, popdc2 and popdc3, which 
have been both been identified in mouse, human, and chicken (Andree et al. 
2000).  The gene structure and sizes of popdc family members have been 
determined (Table 1). The chromosomal location of the popdc2 and popdc3 
genes has been determined in many species (Table 1).  Mouse popdc3 is located 
in close proximity to bves on chromosome 10 while popdc2 is on chromosome 
16.  Similarly, human popdc3 has been mapped to chromosome 6q21 (like bves), 
while popdc2 has been mapped to chromosome 3q13. Chicken bves and popdc3 
genes are both located on chromosome 3 and popdc2 is on chromosome 1. 
However, not all species have multiple popdc genes. To date, only one transcript 
has identified in Xenopus (Hitz et al. 2002; Ripley et al. 2006), and in Drosophila 
through EST databases and cDNA cloning (NCBI). 
In summary, popdc genes appear in a broad spectrum of invertebrate and 
vertebrate species. Due to potential redundancy of popdc gene family members, 
genetic analysis of function may proceed more rapidly in organisms that have 
only one gene, whereas studies in mice, which are essential for understanding 
mammalian gene function, will apparently require disruption of two or more of the 
genes (Andree et al. 2002). 
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Protein Size and Structure 
 
The full-length protein sequence of bves has been determined in chicken (357 
a.a.), mouse (358 a.a.), and human (360 a.a.) (Table 1). Conservation of Bves 
protein sequence exists across a wide variety of vertebrate species (~80%; 
Figure 1). At present, groups studying Bves are in agreement that the protein 
possesses three transmembrane domains and has an extracellular glycosylated 
N-terminus and intracellular C-terminus (Figure 1) (Andree et al. 2002; Knight et 
al. 2003).  A closer examination of sequence similarity reveals that certain 
regions of the protein exhibit higher degrees of homology (Figure 1). For 
example, while the amino acid sequence of chick and mouse are 75% 
homologous, the highest degree of homology (92%) lies within the C-terminus.  
Outside of the regions that encode glycosylation sites, the N terminal sequence is 
rather diverse across species (Andree et al. 2000). While I will focus on the gene 
product, Bves, from this point forward, I will mention that the mouse, chick, and 
human popdc2 encodes a ~360 a.a. (41kD) and popdc3 encodes a ~290 a.a. 
protein, which has a shorter C-terminus (37kD) (Table 1).  Like Bves, the 
additional gene products in the Popdc family are highly conserved across species 
(~80%) (Table 1). However, within a single species Bves is ~25% homologous to 
Popdc2 and Popdc3.  Interestingly, Popdc2 and Popdc3 are ~50% identical, 
indicating that these gene products are more closely related to each other than to  
 7 
 
 
 
 
 
Figure 1:  Alignment of vertebrate Bves sequences. Bves is highly conserved across species. 
Transmembrane/hydrophobic sequences are contained by red boxes. The Popeye domain is denoted (black line). 
Sequences to which antibodies were generated are indicated by blue (D033), green (XBves), and low (B846) lines. An 
additional monoclonal antibody generated by DiAngelo et al. (2001) was raised against amino acids 91-358 of the chick 
sequence. A pair of lysine residues within the C-terminus, denoted by a pink box, has been shown to be critical for 
epithelial integrity. 
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Bves, which appears to be the outlier of this family. This is surprising in light of 
the arrangement of the three family members in the genome (see Table 1).  
Immunochemical detection of Bves protein yields bands ranging between 
a ~42-48kD under reducing and denaturing conditions (Reese et al. 1999; 
Andree et al. 2000; DiAngelo et al. 2001; Smith and Bader 2006). The size 
variation may result from posttranslational modification of the protein in the form 
of N-linked glycosylation (Knight et al. 2003).  Early computer-based modeling 
predicted that Bves possesses three hydrophobic domains (Reese et al. 1999; 
Andree et al. 2000). Presence of these hydrophobic domains was confirmed and 
shown to be essential for membrane insertion/retention, as demonstrated by in 
vitro transcription/translation reactions in the presence of microsomes (Wada et 
al. 2001). Despite these findings, the structure of Bves was initially difficult to 
resolve and Wada et al. originally reported that the C-terminus of Bves was 
extracellular (2001). Subsequent immunocytochemical and biochemical data 
suggest that the short N-terminus (36-39a.a.) is extracellular, while the longer C-
terminus is intracellular (Knight et al. 2003). Two N-glycosylation sites have been 
found within the N-terminus in all species studied thus far (Knight et al. 2003), 
although the physiological significance of these sites is unknown.  
The C-terminal intracellular portion of the protein is a likely candidate 
region for interactions with other proteins and, thus, its dissection has been a 
primary focus. However, this region of Bves lacks known motifs, such as a PDZ, 
SH3, leucine zippers, or other protein-protein interaction domains that would 
 9 
suggest function. However, a highly conserved domain (a.a. 172-266) in the C-
terminal intracellular portion of Bves for which function(s) is unknown has brought 
about the renaming of the Popeye family to Popdc (popeye domain containing), 
and this newly identified domain may be a motif for protein-protein interaction 
unique to the Popdc family.   The absence of any conserved or characterized 
domains in the Bves protein has greatly complicated early inquiries into the 
function of the protein, as the unique nature of Bves at the amino acid level 
precludes any sort of candidate approach in experimental design.  In the absence 
of known functional domains, it has been necessary to identify interacting 
partners using immunoprecipitation, protein pull-downs, and yeast two-hybrid 
analyses to ascribe function.  Later, I describe the isolation of two interacting 
proteins using genetic screens, and describe the characterization of one of these 
interactions.  
 
Expression of Bves during development 
 
Bves expression has been analyzed at the RNA and protein level in the 
mouse, chick, and frog during various developmental stages (Reese et al. 1999; 
Andree et al. 2000; DiAngelo et al. 2001; Wada et al. 2001; Andree et al. 2002; 
Hitz et al. 2002; Osler and Bader 2004; Ripley et al. 2004; Vasavada et al. 2004; 
Ripley et al. 2006). Interestingly, expression analysis using in situ hybridization or 
antibody detection did not always lead to congruent results, and some of the 
Bves expression data appeared difficult to reconcile. One major point of 
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contention has been the question whether Bves is expressed in the epicardium of 
the heart, and more generally, in epithelial cells. 
Published literature agrees that Bves is clearly expressed in muscle cell 
types. Reese et al. (1999) and Andree et al. (2000) originally identified the Bves 
transcript in a screen for gene expression in the developing chick heart. Without 
doubt, in situ hybridization, Northern blot, RT-PCR, and lacZ knock-in 
experiments have demonstrated that Bves is highly expressed in muscle cells of 
the embryonic heart in all vertebrates examined thus far (Reese et al. 1999; 
Andree et al. 2000; Hitz et al. 2002; Ripley et al. 2006). Immunocytochemical 
studies have confirmed this robust cardiac muscle expression. Using the B846 
polyclonal antiserum (Wada et al. 2001; Osler and Bader 2004; Ripley et al. 
2004), the XBves polyclonal antiserum (Ripley et al. 2006), the 3F11 monoclonal 
antiserum (DiAngelo et al. 2001; Vasavada et al. 2004), Bves has been detected 
in the developing myocardium of embryos and in the adult heart. Expanded 
analysis of both mRNA and protein expression have detected Bves in skeletal 
muscle of chick, mouse and frog (Andree et al. 2000; Andree et al. 2002; Ripley 
et al. 2006). It should be noted that Hitz et al. (2002) report no Bves expression in 
the skeletal muscle of Xenopus embryos by in situ hybridization. The reason for 
this conflicting result is presently not known. Interestingly, Swalla and colleagues 
found an ascidian popdc gene to be expressed in cells of the primordial heart and 
tail muscle lineages, suggesting a conserved function for Bves in striated muscle 
across species (Davidson et al. 2003).  Taken together, these published studies 
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permit the conclusion that Bves is expressed in all striated muscle continuously 
from development through adulthood. Furthermore, primary and immortal 
myocyte cell lines have been employed to analyze Bves expression and 
localization in a cell culture system. Overall, the published work pertaining to 
Bves expression in muscle indicates that Bves mRNA and protein are clearly 
observed in cardiac, skeletal, and smooth muscle types (Table 2). 
The tissue around which much of the dispute in the literature was centered 
was the epicardium.  While a thorough discussion of the epicardium and its 
significance will not be included here, a brief introduction to the epicardium and 
development of the coronary vasculature will be presented. During the process of 
cardiac looping, the epithelial proepicardium migrates to the surface of the 
myocardium, proliferates rapidly, and covers the surface of the myocardium 
(Viragh and Challice 1981; Viragh et al. 1993; Mikawa and Gourdie 1996).  This 
epithelium persists through development and adulthood, comprising the 
epicardium and pericardium.  A subpopulation of cells of the epicardium undergo 
an epithelial-mesenchymal transition, delaminate from the epithelial epicardium, 
and infiltrate the developing myocardium (Mikawa and Gourdie 1996; Reese et 
al. 1999).  These mesenchymal cells give rise to the smooth muscle, vascular 
endothelium, and cardiac fibroblasts of the coronary vasculature (Mikawa and 
Gourdie 1996).  The presence or absence of Bves in the proepicardium and 
mature epicardium, as well as in the derivatives of these tissues, has been a 
central topic of debate in the literature
 12 
 
 
 
 
Table 2: Expression data are reported as interpreted by published literature. Sources are numbered in order of 
publication date. Corresponding numbers are used to indicate expression findings in chart form based on technique. A 
consensus of expression is presented as positive, negative or both, in the case where conflicting reports exist. Reference 
numbers with a strikethrough indicate that expression was analyzed in the noted report and not observed. A question 
mark indicates that the expression has not been tested and/or determined. Species are abbreviated as C (chick), M 
(mouse), H (human), X (frog), not applicable (n/a). 
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EST database searches suggested that the message also existed in non-
striated muscle sources. Using Northern blot and RT-PCR analyses, the Bves 
transcript was identified in other organs such as the brain, kidney, stomach, lung, 
spleen, and the uterus of a pregnant mouse, (Andree et al. 2000). Based on 
these data and the results described above, Brand and co-workers hypothesized 
that Bves is expressed within the smooth muscle of these organs. However, 
Northern blot and RT-PCR analyses of organs or tissues do not allow the 
identification of the specific cell types expressing a certain transcript, presenting 
a disadvantage of these techniques for detailed expression studies at the cellular 
level. Using immunocytochemistry, Bves protein has been detected in the smooth 
muscle surrounding the coronary vessels and in gastric visceral smooth muscle 
(Reese and Bader 1999; Wada et al. 2001), but also in epithelia, as discussed 
below. Analysis of Bves lacZ knock-in mice further suggested Bves expression 
exists in the smooth muscle of the gut tube, notochord, and neural tube (Andree 
et al. 2002). While absolute resolution has not been reached concerning vascular 
smooth muscle expression, literature agrees that Bves is present in several 
smooth muscle cell types throughout the embryo.  
Several lines of evidence indicate that Bves is expressed in epithelial cell 
types, in addition to expression in various striated and smooth muscle cells. 
Since Bves had originally been isolated from a screen for heart-specific genes 
(Reese et al. 1999; Andree et al. 2000), the expression pattern was consequently 
expected to be restricted to the cardiac muscle progenitors and the myocardium. 
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Thus, the initial investigations concentrated only on heart development, with a 
broadened focus on muscle development upon detection of the gene/protein in 
skeletal and smooth muscle. Consequently, studies of Bves expression were 
extended to embryogenesis as a whole. Following comprehensive mRNA and 
protein analysis in many species, Bves was found to be expressed in a large 
variety of epithelial tissues in addition to muscle (Wada et al. 2001; Osler and 
Bader 2004; Ripley et al. 2004; Vasavada et al. 2004; Osler et al. 2005; Ripley et 
al. 2006)(Table 3).  
While existing data do not suggest whether Bves is restricted to a 
particular subset of epithelia, the protein is expressed in all three germ layers of 
the developing embryo, and in many epithelial structures during morphogenesis 
and in the adult (Osler and Bader 2004; Ripley et al. 2004; Osler et al. 2005; 
Ripley et al. 2006). The first clue that Bves could be a significant epithelial 
component arose with the identification of expression in the chick proepicardium 
and its derivative, the epicardium. (Figure 2A, Table 3). To this point, Bves 
expression in the epicardium has been detected using several monoclonal and 
polyclonal immunoreagents in chick and mouse embryos (Reese et al. 1999; 
Wada et al. 2001; Osler and Bader 2004; Vasavada et al. 2004). However, Bves 
expression in chick epicardium was reported to be of transient nature in one 
particular analysis using a monoclonal α-Bves antibody (Vasavada et al. 2004). 
These data point out that the persistence/continuity of Bves expression in the 
epicardium is not resolved at present. Furthermore, all reports of epicardial  
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Figure 2:  Bves expression in muscle and epithelia. A: B846 polyclonal 
immunoreagent detects Bves (red) in the epithelial epicardium (epic), 
delaminated migratory cells (arrows), and myocardium (myo) in a section through 
a developing chick heart. Smooth muscle actin (green) labels forming coronary 
vessels (cv) in the subepicardial space. B: Five-day frog embryo labeled with -
XBves (green). Positive cells are found in the epidermis (ep), the developing 
heart (h), and the velar plate (arrows). C: Bves is distributed at the cell 
circumference in cultured human corneal epithelial cells, as labeled by B846 
polyclonal antisera. D: Bves is detected by -Bves B846 (red) in the serosa (ser), 
the smooth muscle (sm), and the gastric epithelium (arrows) of the adult mouse 
intestine. The 4,6-diamidine-2-phenylidole-dihydrochloride (DAPI) labels the cell 
nuclei (blue). E: -XBves detects epithelium (arrows) and the smooth muscle (sm) 
cells of the adult Xenopus gut (green). F: Xenopus Bves is recognized by -XBves 
in the epithelial layers of the adult frog eye, including the cornea (cor) and retina 
(ret). 
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Table 3:  Expression data are reported as interpreted by published literature. Sources are numbered in order of 
publication date. Corresponding numbers are used to indicate expression findings in chart form based on technique. A 
consensus of expression is presented as positive, negative, or both, in the case where conflicting reports exist. Reference 
numbers with a strikethrough indicate that expression was analyzed in the noted report and not observed. A question 
mark indicates that the expression has not been tested and/or determined. Species are abbreviated as C (chick), M 
(mouse), H (human), X (frog), not applicable (n/a).expression come from studies in the chick embryo and it remains 
unclear whether this observation could be species-specific. 
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In addition to the epicardial epithelium, Bves is detected in a variety of 
other epithelia, including the gut epithelium and the serosa, epithelia of the 
respiratory system, the epidermis, the eye and the ependyma  (Osler and Bader 
2004; Ripley et al. 2004; Ripley et al. 2006) (Figure 2). Of these organs, the eye 
expression pattern is of particular interest since Duncan and colleagues identified 
the Bves transcript from a screen for genes essential for eye development 
(Duncan, personal communication). Importantly, proper eye development results 
from appropriate orchestration of signals between the primordial retina, lens and 
cornea, all of which are epithelial in nature. Unpublished work in Xenopus 
underscores the importance of Bves in epithelial morphogenesis of the eye, as 
development is impaired following XBves depletion (Osler, unpublished data). 
Notably, the Bves transcript has also been detected by RT-PCR in early 
embryonic stages in the chick and frog, prior to differentiation of the heart and 
skeletal muscle (Osler and Bader 2004; Ripley et al. 2004; Ripley et al. 2006). 
This supported the idea that Bves must be an epithelial component, since the cell 
layers of early, gastrulating embryos are epithelial in nature, and lack muscle 
gene expressing cells.  
Epithelial cell lines have permitted the analysis of Bves expression in a 
controlled culture system. Our group demonstrated a conserved presence in 
clonal epithelial cell lines of endodermal, mesodermal and ectodermal origin, as 
predicted by expression in embryos (Wada et al. 2001; Osler and Bader 2004; 
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Ripley et al. 2004). Antibodies (B846, D033, XBves) recognize Bves in various 
epithelia and clearly show this protein is present in epithelia (Figure 2; Table 3).   
Despite the agreement of investigators in the field concerning Bves 
expression in cardiac and skeletal muscle, numerous disagreements still exist 
about expression in other cell types.  As stated above, expression in epithelial 
cells and some smooth muscle remains a topic of debate in the literature.  While 
immunochemical analyses indicate that Bves is expressed in a variety of 
epithelial cell types and in cardiac smooth muscle; surveys of expression 
involving detection of bves message disagree with these findings.  It is critical to 
resolve the discrepancies in this field regarding expression, as important 
inferences concerning protein function can be made from expression patterns 
(Kamberov et al. 2000; Roh et al. 2002; Hurd et al. 2003; Roh et al. 2003).  For 
example, if Bves were found to be a protein expressed specifically in striated 
muscle, this would indicate that the function of Bves might be a “muscle-type” 
function, such as contraction, response to electrical stimulus, or adhesion 
between myocytes (Wang et al. 1999; Sinn et al. 2002).  However, determination 
that Bves is not restricted to muscle would preclude many of these potential 
functions, and indicate that Bves may have a more “generic” function that would 
be applicable to a broader range of cell types.  In a following chapter, I describe 
our efforts to remove these discrepancies from the field through generation of a 
panel of Bves-specific monoclonal antibodies, and our subsequent survey of 
Bves expression during murine embryogenesis 
 19 
Function 
 
Of course, the most important scientific question about Bves is: What is 
the function of the Bves protein?  The lack of identifiable protein motifs and a 
potential redundancy of function between members of the Popdc gene family in 
coelomates have made ascertainment of Bves function difficult. By necessity, 
initial experiments conducted to determine function were broad in nature. 
Thomas Brand and colleagues published the first report of a Bves-null mouse 
(Andree et al. 2000). These animals displayed no overt embryonic phenotype 
(Andree et al. 2002), presumably due to redundant functions of Bves with Popdc2 
and 3. However, the adult mice showed a delay in skeletal muscle regeneration 
in vivo following cardiotoxin injection. Attempts to determine the developmental 
function using genetics in the mouse await generation of an animal where all 
Popdc genes are inactivated.  
Genetic analyses in Drosophila and zebrafish are also attractive, as only 
one Popdc family gene is present in Drosophila, while the number is currently 
unresolved in zebrafish. Recently, Bader and colleagues addressed function in 
vivo by depleting the X. laevis Bves homolog in developing frog embryos (Ripley 
et al. 2006). In this study, Ripley and Osler et al. show that global depletion of 
XBves by α-XBves morpholino oligonucleotides (Gene Tools, Inc.) causes a 
gastrulation block, while clonal depletion of XBves results in rogue movements by 
the progeny of the injected cell.  These findings underscore the essential nature 
of this protein in large-scale epithelial rearrangements that occur during early 
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development (Ripley et al. 2006).  However, these experimental findings do not 
indicate any sort of molecular mechanism for Bves, nor do they explain how 
alteration of Bves expression leads to the observed phenotypes. 
In the absence of genetic systems, advances in examination of Bves 
function have developed from in vitro studies using cell culture models (Wada et 
al. 2001; Ripley et al. 2004; Osler et al. 2005). Early findings support a role in 
cell-cell adhesion/cell-cell interaction. Experiments using fibroblastic L-cell 
hanging-drop aggregation assays support an adhesive function for Bves. These 
standard adhesion assays demonstrated that transfection of chicken, Xenopus, 
or Drosophila Bves resulted in increases in cell-cell adhesion in these normally 
non-adherent cells (Wada et al. 2001; Ripley et al. 2006).  
Published work from the Brand and Bader groups points to Bves-Bves 
homophillic interaction in both N- and C-termini (Wada et al. 2001; Andree et al. 
2002) and supports the results of L-cell adhesion assays. Vasavada et al. have 
also demonstrated that Bves in its native conformation forms dimers (2004) 
(Figure 3). Whether Bves heterophillically interacts with related Popdc family 
members is currently unknown.  Additional work from the Backstrom laboratory 
has indicated that intermolecular disulphide bonding plays a role in Bves-Bves 
interactions (Knight et al. 2003). Thus, it is plausible that oligomeric forms of 
Bves participate in cell-cell interaction at some level.  Clearly, evidence exists 
from a variety of experimental methods that Bves is important for cell-cell 
interaction/adhesion. 
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Figure 3:  Predicted structure of Bves.  Bves, a protein containing ~360 
amino acids, is predicted to have 3 transmembrane domains.  The extracellular 
amino terminus possesses two N-linked glycosylation sites.  The intracellular C-
terminal tail contains a domain responsible for oligomerization (Kawaguchi and 
Bader, unpublished results) and the Popeye domain, a common feature of all 
popdc family members.from a variety of experimental methods that Bves is 
important for cell-cell interaction/adhesion. 
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Epithelial cells express Bves at points of cell-cell contact, reminiscent of 
proteins involved in cell adhesion (Osler et al. 2005). In confluent epithelial cells, 
Bves surrounds the cell border and significantly colocalizes with TJ proteins 
Occludin and ZO-1 (Osler et al. 2005). As previously stated, investigation of Bves 
interaction with other proteins is a critical avenue of exploration for determination 
of Bves function as little indication of function is provided by analyses of domains 
contained in the Bves protein.  GST pull-down analysis demonstrated an 
interaction between the intracellular C-terminus and a protein complex containing 
ZO-1 (Osler et al. 2005). ZO-1 is a scaffolding protein that interacts with a 
multitude of tight, adherens and gap junction proteins (Itoh et al. 1993; Fanning et 
al. 1998; Itoh et al. 1999; Barker et al. 2001).  
Consequently, the localization and interaction at the TJ led to a functional 
assessment of TJ integrity in Bves-depleted human corneal epithelial cells. 
Knockdown of Bves in epithelial cells leads to a disruption of epithelial sheet 
integrity, a concomitant loss of transepithelial resistance, and displacement of 
ZO-1 from the TJ domain, further suggesting interaction between Bves and the 
TJ (Osler et al. 2005).  While this finding indicates that Bves somehow affects TJ 
integrity in epithelia, perhaps through an interaction with ZO-1, neither the nature 
of this interaction nor the precise domain of Bves that interacts with ZO-1 have 
been determined.  While this interaction and phenotype are interesting, a 
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mechanistic explanation for how the interaction of Bves with a protein complex 
containing ZO-1 may be potentiating this phenotype is lacking at this time.   
In summary, the function of Bves has been largely undetermined.  
Tantalizing phenotypes, such as the epithelial wound assay, tight junction 
perturbation upon Bves depletion, defective cellular organization during Xenopus 
gastrulation upon Bves knockdown, and delays in skeletal muscle regeneration 
upon Bves global inactivation exist, yet no molecular mechanism has been 
determined to explain these phenotypes.   I have determined that Bves interacts 
with GEFT, a protein that modulates small Rho-GTPase signaling.  This 
interaction, and its effects on Rho-GTPase signaling, provides the first 
description of a protein that interacts with Bves directly and provides a molecular 
mechanism for the Bves protein that may explain some or all of the phenotypes 
listed above.   
 
Small GTPase signaling 
 Small GTPase signaling plays a variety of roles in the developing embryo 
as well as the mature organism.  GTPases serve as the molecular switches for 
cellular processes such as migration and shape change via regulation of the actin 
cytoskeleton (Kaibuchi et al. 1999).  Myriad cellular activities, including formation 
of stress fibers, cellular morphology, aggregation, motility, membrane ruffling, 
lamellipodia formation, filopodia formation, cytokinesis, and cellular adhesion 
have all been demonstrated to be controlled by the Rho-family GTPases 
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(Kaibuchi et al. 1999).  This family consists of at least 10 members in mammals, 
among those are Rac1, Cdc42, and RhoA—the three best understood members 
of the Rho GTPase family.   
 Rho-family GTPases bind to both GTP and GDP, and have intrinsic 
GTPase activity.  These proteins cycle between a GTP-bound active state and a 
GDP-bound inactive state.  Several accessory proteins modulate this exchange 
activity, such as GEFs (guanine nucleotide exchange factors), GAPs (GTPase 
activating proteins), and GDIs (GDP dissociation inhibitor).  GEFs stimulate the 
release of GDP from small GTPases, which in turn leads to increased GTP 
binding, thereby activating the small GTPase (Cerione and Zheng 1996).  GDIs 
play the opposite role by repressing the dissociation of GDP from GTPases, thus 
favoring the inactive state of these proteins (Takai et al. 1995).  GAPs stimulate 
the GTPase activity of GTPases, leading to their conversion to a GDP-bound 
inactive state (Takai et al. 1995).  In summary, these proteins regulate GTPase 
activity along the following broad cyclical pathway:  GDP-bound GTPases 
(inactive) in the cytoplasm are complexed with GDIs.  When a signal for 
activation is received, GEFs stimulate dissociation of GTPases and GDIs.  GDP 
dissociates from the GTPase, and the GTPase then binds free GTP in the 
cytoplasm (active).  The active GTP-bound GTPase is then targeted to the 
membrane where it interacts with its targets.  GAPs enhance the intrinsic 
GTPase activity of these GTP-bound proteins, catalyzing conversion to a GDP-
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bound (inactive) state.  At this point, GTPases complex with GDIs to begin the 
cycle again (Figure 4) (Kaibuchi et al. 1999). 
 Rho-family GTPases have numerous targets, some of which are shared 
between family members, and some of which are specific to a particular GTPase 
(Kaibuchi et al. 1999).  Rho targets in mammalian cells include Rho-kinase, 
myosin phosphatase, PRK1, rhophilin, rhotekin, citron, and p140mDia (Van Aelst 
and D'Souza-Schorey 1997).  These effectors elicit a variety of cellular activities, 
including smooth muscle contraction (Amano et al. 1996; Kimura et al. 1996), 
stress fiber formation (Leung et al. 1996; Amano et al. 1997), neurite retraction 
(Amano et al. 1998), cytokinesis (Yasui et al. 1998), and actin polymerization 
(Watanabe et al. 1997).   
Rac1 and Cdc42 target p21 activated kinases (PAKs), WASP and N-
WASP, IQGAP1, MRCK, Por1, p140Sra-1, and Posh .  Rac1 and Cdc42  share 
several of these targets.  Formation of lamellipodia and filopodia (Miki et al. 
1998), degradation of stress fibers and focal adhesions (Manser et al. 1997; Sells 
et al. 1997), activation of JNK and p38 transcriptional cascades (Bagrodia et al. 
1995; Zhang et al. 1995) have all been shown to be regulated by these 
Rac1/Cdc42 effectors.  Interestingly, activation of some of these effectors 
functions as positive feedback mechanisms to propagate GTPase signaling 
(Manser et al. 1998).     
 These small GTPases are critical for control of a number of cellular 
processes, and commonly function as a “relay” between extracellular signals and 
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Figure 4: In resting cells, Rho-famliy GTPases exist mostly in the GDP-bound 
form and in complexes with GDIs (GDP dissociation inhibitors) in the cytosol. 
When cells are stimulated with the appropriate extracellular factors, Rho-family 
GTPases are probably dissociated from GDIs and targeted to specific 
membranes by its carboxy-terminal prenyl group. At the membrane, specific 
GEFs (guanine nucleotide exchange factors) for Rho-family GTPases are 
activated and GDP-GTPase is then converted to GTP-GTPase. GTP-GTPase 
interacts with specific effectors to exert its functions. GAPs (GTPase-activating 
proteins) enhance the GTPase activity of Rho-family GTPases and reconvert 
GTPases to their inactive GDP-bound form.  GDIs can then form a complex with 
GDP-GTPases and extract it from the membrane back into the cytosol. (adapted 
from Fukata and Kaibuchi, 2001) 
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intracellular processes.  In many cases, the intracellular process most directly 
affected by Rho-family GTPase signaling is the dynamic organization of the actin 
cytoskeleton.  Via control of the cytoskeleton, Rho GTPases are able to exert 
influence upon are numerous cellular processes.   
 For example, control of the actin cytoskeleton during cell-cell and cell-
matrix adhesion is exerted through the Rho GTPase family.   Integrins, which link 
the cytoskeleton to the extracellular matrix, activate both Rac1 and Cdc42, and 
this activation is critical for normal cell spreading (Price et al. 1998; del Pozo et 
al. 2000).  Similarly, cadherin signaling during formation of adhesion complexes 
also activates Rac1 and Cdc42, while repressing RhoA.  Disruptions of these 
GTPase activations and repressions have been shown to block the formation of 
cell-cell adhesions (Braga et al. 1997; Hordijk et al. 1997; Kuroda et al. 1997; 
Zhong et al. 1997; Jou and Nelson 1998). 
 Perhaps the most commonly known function of the Rho GTPases is 
control of processes that govern cellular motility.   In Swiss 3T3 fibroblasts, Rac1, 
Cdc42, and RhoA are all activated during cell motility.  On the leading edge of 
movement, Rac1 and Cdc42 are active, producing filopodia and lamellipodia.  
The combination of this protrusive activity driven by Rac1 and Cdc42 coupled 
with acto-myosin based retraction on the trailing edge, catalyzed by RhoA 
activity, allows directed cellular movement in response to extracellular cues  
(Figure 5) (Etienne-Manneville and Hall 2002).  Complex processes regulated by 
Rho GTPases, such as cell motility, are closely regulated by crosstalk between 
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Figure 5:  Independent movement controlled by Rho-family GTPase signals. 
Cells move through the polarized and dynamic re-organization of the actin 
cytoskeleton, involving a protruding force at the front (blue arrows), combined 
with a contractile force in the cell body (double-headed red arrows). This 
contractile activity leads to retraction of the rear of the cell as the adhesions are 
lost (single-headed red arrows). Rho-family GTPases act spatially and temporally 
to control all these aspects. Rac regulates actin polymerization at the front to 
promote protrusion. Cdc42 acts at the front to control direction in response to 
extracellular cues. Rho stimulates actin-myosin contraction in the cell body. 
Invading cancer cells are probably not directed by outside signals, but 
deregulated Rac is thought to have an important role. b, Coordinated movement. 
In in vitro scratch assays, cells sense the free space left by the scratch and 
migrate together as a sheet. Rac is essential for forward movement in fibroblasts. 
Migrating cells are oriented perpendicularly to the scratch. How cells behind the 
front row migrate coordinately with front row cells is unclear, but may involve 
secretion of soluble factors and/or mechanical tension.  The Rac1/Cdc42-
dependent secretion of a soluble TGFbeta-like factor (in blue) is required to 
promote migration of the entire monolayer. When cells approach each other, 
Cdc42- and Rac-dependent filopodia and lamellipodia protrude to execute  
wound closure.  (Adapted from Etienne-Manneville and Hall, 2002) 
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members of the Rho GTPase family.  These mechanisms are poorly understood 
at this time, and vary by cell type in which they exist, but are the topic of active 
investigation. 
 It is clear that the Rho-family GTPase signaling pathway is a key regulator 
of many cellular processes.  Data presented in a later chapter demonstrate that 
Bves interacts with GEFT, a protein that directly controls the activity level of Rho 
GTPases (Guo et al. 2003).  The interaction of Bves with a regulatory component 
of this signaling pathway not only has important implications for understanding 
the function of Bves, but also for developing a more complete understanding of 
Rho-family GTPase signaling and how it controls the variety of cellular behaviors 
previously described.       
 
The Dbl-family of guanine nucleotide exchange factors 
 As mentioned previously, GEFs stimulate GDP dissociation from 
GTPases.  This dissociation catalyzes GTP binding to GTPases, as the cytosolic 
concentration of GTP is 5x higher than the concentration of GDP (Cerione and 
Zheng 1996).  The activation of Rho-family GTPases through these proteins is 
often stimulated by extracellular signals via various cell-surface receptors.  
Receptors of the tyrosine kinase, adhesion, cytokine, and GPCR families all 
stimulate downstream Rho-family GTPase activity (Kjoller and Hall 1999; Sah et 
al. 2000).   The intermediates between cell-surface receptors and GTPases 
activation are GEFs.   
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 The prototypical mammalian Rho family GEF is Dbl.  This GEF was 
isolated from diffuse B-cell-lymphoma cells (Eva et al. 1988; Hart et al. 1991).  
This protein was found to share a highly conserved domain with Cdc24, a 
Saccharomyces cerevisiae protein that interacts with Cdc42 during yeast budding 
and polarity.  Later, Dbl was demonstrated to have GEF activity for human 
Cdc42.  69 distinct members of the Dbl family of GEFs have since been identified 
(Rossman et al. 2005). 
 Dbl family GEFs, for the most part, share two conserved domains:  the Dbl 
homology domain (DH) and the pleckstrin homology domain (PH).  DH domains 
catalyze the exchange of GDP for GTP by Rho-family GTPases by promoting a 
“nucleotide-free” state, thereby stimulating GTP binding due to the relative higher 
cytosolic GTP concentration.  The DH domain elicits this functional activity by 
interaction with the switch regions of Rho-family GTPases, altering the 
nucleotide-binding pocket and disrupting the proper structural conformation 
necessary for GDP binding (Rossman et al. 2002).  While some Dbl GEFs are 
promiscuous in their binding to GTPases, others are specific to one GTPase, and 
this specificity is likely determined by uniqueness within the DH domain (Schmidt 
and Hall 2002). 
PH domains serve to localize Dbl GEFs to plasma membranes.  Through 
control of localization to sites where nucleotide exchange activity occurs, and 
allosteric interactions, PH domains help to regulate Dbl GEF activity.  The PH 
domain is always found C-terminal to the DH domain in Dbl GEFs, although 
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instances of Dbl GEFs with no PH domain do exist (Rumenapp et al. 2002).  
Although the PH domains do not catalyze GTPase activity themselves, their 
presence is important for proper GEF activity.  Experiments have shown that DH-
PH fragments of Dbl GEFs stimulate a higher rate of nucleotide exchange activity 
than the respective DH domains alone (Ron et al. 1991; Whitehead et al. 1995; 
Liu et al. 1998; Rossman and Campbell 2000).  In some cases, investigators 
demonstrated the necessity for PH-domain membrane targeting in GEF function 
by replacing the PH domain with other sequences that direct protein localization 
to the plasma membrane.  Interestingly, PH domains of Dbl GEFs show little 
affinity or specificity for phospholipids, indicating that interaction with the lipid 
bilayer alone is insufficient GEF localization to the membrane (Snyder et al. 
2001) and that interaction with other membrane associated proteins may be 
critical for proper localization of Dbl GEFs to sites where they are needed for 
GTPase regulation.  Here I demonstrate that Bves, an integral membrane 
protein, interacts directly with the Dbl-family GEF GEFT.  This Bves-Geft 
interaction may be one of these interactions that serve to localize a Dbl GEF to 
the proper site of Rho GTPase activity in order to properly control Rho GTPase 
signaling in a variety of cellular events.      
 
Approach to this project 
As outlined in this chapter, Bves is a novel protein that is largely 
uncharacterized.  The domain of expression of this protein is still debated in the 
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literature, the function is undefined, and molecular mechanism of any Bves action 
is completely unknown.  The ability of Bves to affect cellular behaviors during 
epithelial wound healing (Osler et al. 2005), Xenopus development (Ripley et al. 
2006), and skeletal muscle regeneration (Andree et al. 2002) has been reported, 
yet no plausible molecular mechanism for these phenotypes has been offered at 
this time.  In fact, direct interaction with any protein has not been reported, 
although interaction with a protein complex containing ZO-1 has been 
demonstrated (Osler et al. 2005).   
Given that the expression pattern of Bves was disputed, and that no 
directly interacting proteins had been discovered; little evidence for making 
hypotheses of Bves function and molecular mechanism of function existed.  The 
absence of conserved protein motifs also provided no clues with which a 
hypothesis could be logically formulated regarding Bves function.  With this 
knowledge, I first set out to remove the controversy regarding the expression 
pattern of Bves from the literature.  The generation of a new panel of monoclonal 
antibodies specific to Bves, the characterization of these reagents, and the 
definition of the expression pattern of Bves during mouse embryogenesis are 
described in Chapter II.    
 We next hypothesized that definition of Bves-interacting proteins will 
reveal the function of Bves.  Utilizing a yeast two-hybrid screen with an 
embryonic mouse heart library, I discovered a direct interaction between the 
intracellular carboxyl-terminus of Bves and GEFT, a Rho-family GTPase GEF.  
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Characterization of this interaction, as well as our investigation of the functional 
significance of this interaction, is provided in Chapter III.  The relevant 
discussion, our conclusions from the entirety of this data, and potential future 
avenues of research are presented in Chapter IV. 
 
 34 
 
CHAPTER II 
 
CHARACTERIZATION OF BVES EXPRESSION DURING MOUSE 
DEVELOPMENT USING NEWLY GENERATED IMMUNOREAGENTS  
 
 
 
Introduction 
Bves was isolated independently by two laboratories (Reese et al. 1999; 
Andree et al. 2000) using subtractive hybridization screens for heart enriched 
gene products.  Additional members of the gene family (Popdc2 and Popdc3) 
were also isolated (Andree et al. 2000).  Sequence analysis of Bves revealed no 
conserved or predicted functional motifs and no homology to any previously 
identified protein. Three hydrophobic regions near the N- terminus were identified 
that have since been determined to be functional in anchoring the protein to the 
plasma membrane (Wada et al. 2001; Knight et al. 2003). Orthologous genes 
have been identified in numerous invertebrates and vertebrates (Reese and 
Bader 1999; Reese et al. 1999; Andree et al. 2000; Hitz et al. 2002; Ripley et al. 
2006). 
Controversy about the expression pattern of the Bves protein persists in 
the literature. Detection of Bves message through in situ hybridization, Northern 
blotting (Andree et al. 2000), or lacZ knock-in (Andree et al. 2002) do not agree 
with detection of the Bves protein using multiple anti-Bves immunological 
reagents (Reese et al. 1999; DiAngelo et al. 2001; Wada et al. 2001; Osler and 
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Bader 2004; Ripley et al. 2004; Vasavada et al. 2004).  While in situ hybridization 
and lacZ knock-in analyses have been interpreted as indicating that Bves is 
expressed preferentially in cardiac and skeletal muscle, analyses of protein 
expression indicate that Bves is expressed in many epithelial cell types as well.  
The first polyclonal antibody generated by our laboratory, D033, revealed 
expression in the proepicardium, migrating epicardium, epicardial-derived 
mesenchyme and smooth muscle cells of the cardiac arteries of the developing 
chicken heart (Reese et al. 1999).  A second polyclonal antibody, B846, also 
revealed Bves expression in cardiac muscle and all epicardial/epicardially 
derived tissues listed above (Wada et al. 2001), as well as expression in various 
epithelial cell lines (Wada et al. 2001), epithelia of all three germ layers during 
early chick development, epidermis, gut endoderm (Osler and Bader 2004), and 
epithelia of the lens, retina, and cornea (Ripley et al. 2004).  A subsequent 
antibody against the X. laevis ortholog of Bves was developed, and has revealed 
highly similar expression in the frog (Ripley et al. 2006).  A monoclonal antibody 
generated against the chicken Bves protein (DiAngelo et al. 2001) also 
demonstrated that Bves is expressed in skeletal muscle, cardiac muscle, brain, 
and epicardium (Vasavada et al. 2004). The monoclonal antibody generated by 
Duncan and colleagues clearly reacts with the chicken Bves protein in cardiac 
myocytes and transiently in the epicardium, but has not been reported to react 
with chicken Bves protein in other epithelial cell types (DiAngelo et al. 2001; 
Vasavada et al. 2004). 
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Here, I describe the generation of multiple new α- mouse Bves 
monoclonal antibodies that display reactivity with cardiac muscle, skeletal 
muscle, and epithelial cell types throughout embryonic development, as well as 
cultured epithelial and muscle cell lines.  I also thoroughly examine the 
developmental expression profile of the mouse Bves protein using these and 
other previously generated α-Bves reagents.  Thus, I provide a comprehensive 
description of Bves expression at the protein level in the mouse, which is lacking 
in the literature at this time. Our data clearly demonstrate that the Bves protein is 
present in developing muscle and epithelial cell types derived from all three germ 
layers.  These studies are essential for a meaningful understanding of Bves 
function and to determine the role of Bves in mouse embryogenesis.     
 
Materials and Methods 
 
Generation of α-Bves monoclonal antibodies 
Antibodies were generated against the peptide DPTLNDKKVKKLEPQMS 
(amino acids 266-283 of mouse Bves) in collaboration with QEDBioscience (San 
Diego, CA) using standard methodology (Bader et al. 1982).  Antibodies were 
initally screened using ELISA against the original peptide.  Reactive clones were 
selected from this screen and were then subjected to screening using secondary 
immunofluoresence against COS-7 cells transfected with Bves expression 
constructs.  Reactive clones were further characterized using standard 
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immunoblotting procedures against GST-fused Bves, Popdc2, and Popdc3.  
Once isolated, hybridomas were cultured and also injected into the peritoneal 
cavity of mice to generate ascites fluid.  Five independent clones were used to 
generate ascites, and all five of these hybridoma lines will be deposited in the 
Developmental Studies Hybridoma Bank.  
 
Antibodies 
 Primary antibodies against E-cadherin (Chemicon), ZO-1 (Zymed), 
sarcomeric myosin (MF20, DSHB), c-myc (Sigma), cytokeratin (Sigma), and GST 
(Amersham) were applied according to manufacturer’s specifications.  Alexa-488 
and Alexa-568 conjugated secondary antibodies (Molecular Probes) were used 
at 1:4,000 dilutions for indirect immunofluoresence, and alkaline phosphatase 
conjugated secondary antibodies (Sigma) were dilluted 1:10,000 for 
immunoblotting.  DAPI (4’, 6-diamidine-2phenylidole-dihydrochloride; Roche) was 
used to visualize nuclei per manufacturer’s specifications.  When direct labeling 
of antibodies was necessary, Zenon Alexa Fluor labeling kit (Molecular Probes) 
was employed to label primary anitbodies according to manufacturer’s 
specifications.  The polyclonal antibody B846 has been previously described 
(Wada et al. 2001; Osler and Bader 2004).  Newly generated α-Bves monoclonal 
antibody ascites fluids were used at a 1:2,000 dilution for immunohistochemistry 
with both tissue sections and cultured cells.  Samples were incubated in primary 
antibodies at 4°C overnight in a humidified chamber. 
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Western Blotting analysis 
Hearts were excised from adult (~8 weeks) ICR mice (Jackson Labs), and 
dissected into small pieces.  Tissue was then homogenized using extraction 
buffer (1x PBS, 1% Igepal CA-630 (Sigma), 0.5% sodium deoxycholate, 0.1% 
SDS) containing mammalian protease inhibitors (Roche Complete).  Samples 
were then centrifuged at 21,000 x g for 30 minutes at 4°C.  Supernatant was 
collected, and protein concentration assayed using Bradford assay (Biorad).  40 
ug protein was diluted in SDS-PAGE sample buffer, and electrophoresed on a 
10% SDS-PAGE gel at 125 V.  Protein was then transferred to Immobilon-P 
membrane (Millipore), and then blocked in blocking solution (10% nonfat dry milk 
(Carnation), 100mM Tris Cl pH 7.5, 150 mM NaCl, .25% TritonX-100 (Sigma)) 
overnight at 4°C.  Primary antibody (SB1, anti-Bves monoclonal Ab) was applied 
to blot at 1:2000 dilution (~1 ug/mL) for one hour at room temperature.  Blot was 
washed 3 times with 1x TBST (100mM Tris Cl pH 7.5, 150 mM NaCl, .25% 
TritonX-100 (Sigma)), and then incubated with alkaline phosphatase conjugated 
secondary antibodies (Sigma) at manufacturer’s recommended concentrations in 
blocking buffer for one hour at room temperature.  Blot was washed 3 times with 
1x TBST, and binding of secondary antibodies visualized using NBT/BCIP 
(Roche) according to manufacturer’s specifications.   
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Tissue/cell preparation  
Tissues were harvested, washed in cold PBS and then incubated in 20% 
sucrose in PBS overnight at 4°C.  Tissues were then processed for frozen 
sectioning and immunohistochemical staining of using standard methodology 
(Bader et al. 1982; Wada et al. 2003).  Cultured cells were transfected with 
expression constructs using Fugene (Roche) transfection reagent according to 
manufacturer’s instructions.  
 
Immunofluoresence methods for α-Bves monoclonal antibodies 
As this is the first communication employing these immunochemical 
reagents, a protocol generated for their use is provided.  Briefly, tissue sections 
or cultured cells were fixed for 10 minutes in cold 70% methanol, washed three 
times with PBS, and permeabilized with 0.25% Triton X-100 in PBS for 10 
minutes.  Sections/cells were then washed with PBS three times, and non-
specific binding was blocked by incubation with 2% bovine serum albumin in PBS 
for one hour at room temperature.  Ascites fluids were applied at 1:2,000 dilutions 
for 1-16 hours at room temperature.  No variation in background or staining 
intensity was observed over that period.  Alexa-conjugated secondary antibodies 
(Molecular Probes) were added for one hour at room temperature according to 
manufacturer’s specifications.  Subsequent washing was standard.     
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Generation of mammalian and bacterial expression constructs 
 Mammalian and bacterial expression constructs were generated using 
PCR amplification followed by cloning into pCI-neo (Promega) and pGex 5x-3 
(Amersham).  All expression constructs express the portion of the respective 
protein 3’ to the hydrophobic transmembrane domains of Bves.  A c-myc epitope 
tag was also added to the carboxyl terminus of all mammalian expression 
constructs to aid in monoclonal antibody characterization.  
  
Culture of neonatal mouse myocytes 
 Hearts of N2 mice were harvested, mechanically dissociated, and placed 
in cold PBS.  Hearts were placed in 5 mL 0.25% Trypsin-EDTA (Cellgro) for two 
minutes with rapid stirring using mechanical stir bar.  3.5 mL of Trypsin-EDTA 
was removed after two minutes, and replaced with 3.5 mL fresh Trypsin-EDTA.  
The first two fractions of Trypsin-EDTA were discarded, with fractions 3-8 
retained and placed into a 10x volume of myocyte medium (DMEM: 4.5 g/L 
glucose, 0.0025M thymidine, 10 U/mL penicillin, 10 mg/mL streptomycin, 100 
µg/mL gentamycin, 15% NuSerum (Collaborative Biomedical Products)).  
Myocytes were gently pelleted at 650 x G for seven minutes, then resuspended 
in growth media, counted using a hemacytometer, and plated on 100 mm plastic 
dishes at 3x106 cells per dish. 
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Results 
 
α-Bves monoclonal antibodies recognize Bves specifically 
 Immunochemical reagents against mouse and chicken Bves have 
previously been generated and characterized (Reese et al. 1999; DiAngelo et al. 
2001; Wada et al. 2001; Osler and Bader 2004; Ripley et al. 2004; Vasavada et 
al. 2004).  Recently, DiAngelo et al. (2001) have generated a monoclonal 
antibody against the intracellular C-terminus of chicken Bves.  To this point, no 
monoclonal reagents against murine Bves exist and the characterization of 
protein expression in any organism is incomplete.  
Specificity of α-Bves reactivity was initially established using transfection 
of COS-7 cells with a c-myc-tagged Bves expression construct followed by co-
immunofluoresence using α-c-myc and putative Bves monoclonal antibody 
supernatants.  All ten of the antibody-secreting clones that passed the initial 
screening process were reactive with transfected Bves (SB1 is given as an 
example in Figure 6A, i-iii).  Anti-Bves antibodies were then tested for cross 
reactivity with other members of the gene family (Figure 6A, iv-ix) and a non-
related protein, LEK1 (Figure 6A, x-xii) by transfection of COS-7 fibroblasts with 
c-myc tagged Bves, Popdc2, and Popdc3.  All antibodies generated were found 
to react in a similar manner: specifically with Bves and not with other Popdc 
family members or the unrelated LEK1 protein.  
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Figure 6:  Characterization of α-Bves monoclonal antibodies.  SB1 seen to 
be reactive with COS-7 cells transfected with c-myc tagged Bves expression 
constructs, but no labeling of cells transfected with other members of the protein 
family (PopDC2 and PopDC3) is observed (Fig. 6A).  SB family monoclonal 
reagents are also Bves specific in immunoblotting assays against GST-tagged 
fusion proteins.  No reactivity with PopDC2 (Fig. 6B) or PopDC3 (data not shown) 
is observed.  SB1 reacts with a single protein in immunoblotting assays of adult 
mouse heart (Fig. 6C).  Reactive band is visualized at approximately 53 kD. 
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 α-Bves monoclonal antibodies were then tested for specificity in 
immunoblotting assays.  GST-fusion expression constructs of each Bves family 
member were generated, and purified protein was subjected to standard 
immunoblotting procedures.  SB1 is used here as an example.  Again, α-Bves 
monoclonal antibodies were found to react specifically with Bves, and were 
unreactive with Popdc2 (Figure 6B) and Popdc3 (data not shown). 
 α-Bves monoclonal antibodies were also found to react with an 
approximately 53 kD protein in immunoblotting assays using protein samples 
from adult mouse hearts (Figure 6C).  These data demonstrate the reactivity and 
specificity of these reagents for Bves amongst Popdc family members. 
   
α-Bves monoclonal antibodies detect Bves in epithelial cell lines 
 Analyses of Bves expression in the chicken utilizing in situ hybridization 
techniques differ from results obatined using immunochemical methods (Reese 
et al. 1999; Andree et al. 2000; Wada et al. 2001; Osler and Bader 2004; 
Vasavada et al. 2004).  While both methods provide evidence for expression in 
muscle cell types, in situ hybridization assays and immunochemical assays do 
not agree concerning expression in epithelial cell types.  Utilizing cell lines allows 
the examination of Bves expression in a clonal cell population consisting of a 
single cell type.  Having verified specificity of antibodies SB1-SB5, I then tested 
the newly generated antibodies on a variety of cell lines (Figure 7). α-Bves 
monoclonal antibodies revealed expression in cell lines derived from the rat  
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Figure 7:  Bves is expressed in muscle and epithelial cell lines.  Bves expression 
(green) is observed using indirect immunofluoresence and monoclonal antibody 
SB1 (green) with DAPI (blue) staining for nuclei.  Peripheral expression is 
observed in the EMC (epicardial mesotheial cells, Fig 2A) cell line, the HCE 
(human corneal epithelial, Fig. 7C) cell line, and the MDCK (Maldin Darby Canine 
Kidney, Fig. 7D) cell line.  A broader staining pattern is seen in the differentiated 
mouse C2C12 mouse myoblast cell line (Fig. 7B). 
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epithelial epicardium (line EMC, Figure 7A), differentiated mouse skeletal 
myoblasts (line C2C12, Figure 7B), human corneal epithelium (line HCE, Figure 
7C), and canine kidney epithelial cells (line MDCK, Figure 7D).  Intense staining 
in the lateral compartment of the cell membrane is observed in all epithelial cell 
lines tested thus far.  Punctate intracellular staining is also observed in these cell 
lines (see arrowheads, Figure 7C) and in the C2C12 muscle cell line (Figure 7D). 
These patterns are in general agreement with the subcellular distribution 
detected with polyclonal reagents (Reese and Bader 1999; Wada et al. 2001; 
Osler and Bader 2004).  Therefore the SB monoclonal series recognizes Bves in 
a variety of cell types across a spectrum of mammalian species and cell lines, in 
agreement with previously generated reagents. 
 
Bves is expressed in mouse epidermis throughout development 
 While epithelial and muscle cell lines clearly express Bves, these cell lines 
may not reflect embryonic expression of the protein.  To test whether Bves 
protein is present in developing epithelia derived from ectoderm, frozen sections 
of mouse embryos at various stages of development were examined for Bves 
expression using the SB1 antibody.  Expression of Bves protein was observed in 
multiple epithelial tissues.  Using epithelial markers cytokeratin and ZO1 to verify 
staining patterns, I determined that Bves is expressed in the epidermis of the 
mouse throughout development (Figure 8).  At E12.5, Bves is expressed in the 
apical portion in the epidermal layer.  At low power magnification in Figure 8, the  
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Figure 8:  Bves expression in the epidermis during gestation.  Bves expression is 
seen in the epidermis throughout development, as observed by colocalization 
with cytokeratin, ZO-1, and E-cadherin markers at various developmental stages.  
Colocalization of Bves (Fig. 8B) and cytokeratin (Fig. 8A) at E12.5 shows 
expression of Bves in keratin producing cells, which continues throughout 
gestation.  Expression of Bves in subdermal blood vessels is not observed 
(arrowheads, Fig. 8G-8I).  Near the end of gestation, expression of Bves (Fig. 
8K) is seen in the epidermis at a position apical to that of E-cadherin (Fig. 8J).  
Polyclonal anti-Bves antibody (B846, Fig. 3D) and monoclonal anti-Bves antibody 
(SB1, Fig. 8E) show a similar distribution in the epidermis during development.  
DAPI counterstain used to visulalize nuclei in blue (Fig. 8A-L). 
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general colocalization of SB1 and cytokeratin is observed (Figure 8, A-C).  At 
E12.5, Bves is also detected in the apical regions of the developing epidermis.  
Interestingly, while both SB1 and the polyclonal B846 both recognize Bves 
protein in the epidermis (Figure 8, D-F), the distribution pattern of SB1 labeling is 
somewhat broader in the epidermis than that of the polyclonal antiserum.  As 
development proceeds, a high degree of colocalization of Bves and ZO1 is 
observed in the epidermal layer in the lateral membrane (Figure 8, G-I), while no 
Bves expression is observed in the endothelium of the subdermal blood vessels 
(see ZO1 positive cells indicated by arrowheads Figure 8, G and I).  Near the end 
of gestation, an increase in intensity of staining is observed, and the pattern of 
Bves distribution appears to be wider than at earlier points of development. The 
monoclonal antibody SB1 appears to be reactive with Bves protein in very apical 
portions of epidermal cells.  This is exemplified by comparison of the epidermally-
expressed E-cadherin and Bves (Figure 8, J-L).  While both are clearly 
expressed in this epithelium and exhibit domains of overlap, the major deposition 
of Bves is apical to E-cadherin.  Taken together, the data demonstrate Bves 
expression in ectodermally derived epidermis of the mouse. 
  
Bves is expressed in developing cardiac and skeletal muscle 
 The first generation polyclonal antibody D033 (Reese et al. 1999) did not 
react with cardiac muscle. However Andree et al (2000) clearly demonstrated 
that Bves mRNA was expressed at high levels in cardiac myocytes using in situ 
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hybridization.  In addition, DiAngelo et al (2002) used an α-Bves monoclonal 
antibody to show protein expression in avian cardiac myocytes.  Subsequent 
polyclonal antisera from our laboratory also demonstrated Bves expression in the 
heart (Osler and Bader 2004).  To determine the expression pattern and 
subcellular localization of the Bves protein in the mouse heart, an analysis at 
various embryonic stages using SB1 was undertaken.  At E12.5, Bves staining 
using the SB1 antibody is observed in a uniform subcellular pattern in cardiac 
myocytes (Figure 9A).  At later stages and in the adult, staining is most intense at 
the myocyte periphery (Figure 9B).  Polyclonal B846, which has previously been 
used to study Bves expression in epithelial cells (Osler and Bader 2004), also 
reacts with cardiac myocytes.  As previously seen in epidermis (Figure 8), the 
pattern of localization revealed by B846 in myocytes varies from that of SB1. 
Consistent with these results, SB1 recognizes a broader distribution of Bves in 
the myocardium, labeling the entire periphery of the cell (lateral and longitudinal 
surfaces).  A similar pattern is seen in the chicken during embryonic stages using 
the polyclonal antisera B846.  Bves is seen to localize around the entirety of the 
myocyte (data not shown).  However, B846 only recognizes Bves at the 
intercalated disc, and not on lateral surfaces (Figure 10A).  These results are 
consistent with observations in epithelia, where B846 appears only to recognize 
Bves protein at points of cell-cell contact, as the intercalated disc is the only point 
of cell-cell contact for the cardiac myocyte.  Additionally, Bves localizes to 
nascent points of cell-cell contact in reaggregating myocytes (Figure 10B).  This 
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Figure 9:  Bves expression in the heart.  Broad expression of Bves is observed in 
the heart at E17.5 (Fig. 9A) as observed by labeling with SB1 (anti-Bves, green) 
and MF20 (anti-sarcomeric myosin, red).  Negative control using anti-myc 
antibody shows no background reactivity (Fig. 9A).  Nuclei are visualized using 
DAPI (Fig. 9A, 9B)  In the adult heart, subcelllular localiaztion of protein becomes 
more restricted (Fig. 9B).  Bves (red) is observed to localize to periphery of 
cardiac myocytes in definitive myocardium.  Expression of Bves in vascular 
smooth muscle of the coronary arteries is also observed using SB1 (anti-Bves, 
red) and α-smooth muscle actin (green). 
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Fig 10:  Bves localizes to points of myocyte-myocyte contact in vivo and in vitro.  
Anti-bves antibody B846 (Fig. 10A, red) shows Bves colocalizes with Cx43 (Fig. 
10B, green) to the intercalated disc structure in adult mouse heart.  Bves (Fig 
10B ii and Fig 10B v, red) also localizes to myocyte-myocyte contact points in 
primary cultures of mouse N2 myocytes (arrowheads).  DAPI used to visualize 
nuclei in all panels, and anti-sarcomeric myosin antibody MF20 used to label 
myocytes (Fig. 10B i and iv, green). 
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result in highly consistent with observations regarding Bves localization during 
nascent contact formation in cultured epithelia (Osler et al. 2005).   
It is of interest to note that SB1-5 also detect Bves expression in not only 
in cardiac myocytes, but also in smoooth muscle cells of the coronary system (as 
seen by colocalization with α-smooth muscle actin, Figure 9B) in agreement with 
our previous studies (Reese et al. 1999; Wada et al. 2001).  Andree et al (2000) 
report Bves mRNA expression in somites and delveoping skeletal muscle.  In 
agreement with those studies, SB1-5 also detects Bves protein in developing 
skeletal muscle (Figure 11).  In skeletal myocytes, as confirmed by colocalization 
with the α-MHC monoclonal antibody MF20, SB1 reveals strong Bves 
expression.  The polyclonal α-Bves reagent B846 also recognizes this Bves 
expression in skeletal myocytes.  Note that the epithelial epidermis (arrowheads, 
Figure 11) is positive for SB1 while MF20 labeling is negative; however both 
antibodies are positive for adjacent skeletal muscle. Interestingly, Bves 
expression is also seem in the epithelial somite early during musculogenesis 
(data not shown).    
 Expression of Bves in the epicardium has been debated and remains 
controversial at this time. While in situ hybridization studies did not yield 
significant signal in the epicardium (Andree et al. 2000), monoclonal (DiAngelo et 
al. 2001) and polyclonal antibodies (Reese et al. 1999; Wada et al. 2001; Osler 
and Bader 2004) detect transient or sustained expression of Bves in the 
epicardium.  Thus, it is important to note that our initial observations using the 
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Figure 11:  Bves expression in developing skeletal muscle at E17.5.  Bves expression is visualized using SB1 antibody (Fig. 11B and 11H, green) 
and MF20 antibody is used to visualize sarcomeric myosin (Fig. 11A and 11G, red).  Co-labeling with MF20 demonstrates expression in skeletal 
muscle. Note that the epithelial epidermis (arrowheads) is positive for SB1 while MF20 labeling is negative; while both antibodies are positive for 
adjacent skeletal muscle.  Polyclonal antiserum (B846, Fig. 11D) also recognizes Bves expression in skeletal muscle in a similar pattern to anti-
Bves monoclonal antibody (SB1, Fig. 11E).  DAPI used to visualize nuclei in blue (Fig. 11A-I).
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reagents and methods described here do not detect Bves protein in the definitive 
epicardium, even though these antibodies are highly reactive with the epicardially 
derived EMC cell line (Figure 7A). 
 
Bves is expressed in epithelia of the lung and esophagus during development  
 We next tested SB1 antibody reactivity in endodermally derived epithelium 
using lung and gut epithelium as examples of this cell type.  Bves is detected in 
the epithelial components of the digestive tract and lung during development.  
Particularly, strong expression in the esophagus and main bronchi is observed at 
E14.5 (Figure 12).  As confirmed by co-expression of E-Cadherin, these cells are 
the epithelial linings of these passageways.  However, the expression of Bves in 
the respiratory system appears to be restricted to the trachea and larger bronchi, 
while expression in smaller airways is not observed at high levels.  Comparison 
of Bves and E-cadherin staining demonstrates that Bves protein distribution is 
not uniform in the epithelium of the respiratory system, while expression in the 
esophagus appears to be more evenly distributed.  These data clearly 
demonstrate the expression of Bves in endodermally derived epithelium.    
 
Discussion 
 For a meaningful understanding of protein function during development or 
in the adult, it is essential to determine the domain of expression of the protein.  
The expression of Bves has been a topic of debate since the initial experiments  
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Fig 12:  Bves expression in epithelial components of the digestive and respiratory 
tracts.  Bves labeled using SB1 antibody(Fig. 12B, green) is observed in epithelia 
of the esophagus as seen by colocalization with ZO1 (Fig. 12A, red).  Expression 
of Bves (Fig. 12D, green, SB1 antibody) in a subset of epithelial cells that line 
bronchi is demonstrated through colocalization with E-cadherin (Fig. 12C, red).  
Nuclei are visualized in blue using DAPI (Fig. 12A-F).  Note that not all epithelial 
cells in respiratory passageway are Bves positive, and that Bves expression is 
absent in smaller airways.  (Eso. = esophagus, Br. = bronchi) 
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characterizing the gene.  The expression of Bves has been previously examined 
using polyclonal antisera in the developing chick and frog (Reese et al. 1999; 
Wada et al. 2001; Osler and Bader 2004; Ripley et al. 2004; Vasavada et al. 
2004; Ripley et al. 2006), in situ hybridization in the develoing chick (Andree et al. 
2000) and frog (Hitz et al. 2002; Ripley et al. 2006), lacZ knock-in (Andree et al. 
2002; Andree et al. 2002), RT-PCR (Wada et al. 2003; Osler and Bader 2004), 
and Northern blotting (Reese et al. 1999; Andree et al. 2000; Andree et al. 2002).  
However, despite the utilization of these many methods in several model 
systems, disagreement in the literature still persists regarding the expression 
pattern of this protein.  While some reports indicate that the expression of the 
protein was either restricted to or highly enriched in cardiac, skeletal, and smooth 
muscle (Andree et al. 2000; Andree et al. 2002; Andree et al. 2002; Hitz et al. 
2002); other reports have strongly supported a broader expression pattern that 
extends to many epithelial cell types (Reese et al. 1999; Wada et al. 2001; Wada 
et al. 2003; Osler and Bader 2004; Ripley et al. 2004; Vasavada et al. 2004).  
Here, using newly generated monoclonal reagents, I show that Bves is 
expressed in tissues derived from all three germ layers, various epithelia and in 
epithelial cell lines, and in smooth and striated muscle. 
My goal was to develop reagents to more precisely determine the 
expression pattern of the Bves protein, and to examine the expression of Bves 
during mouse development.  As expected, expression of Bves was observed in 
skeletal and cardiac muscle (Figure 11 and Figure 9, respectively).  This is in 
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agreement with previous analyses of Bves mRNA expression and with antibody 
studies from the Duncan and Bader laboratories (Reese et al. 1999; Andree et al. 
2000; DiAngelo et al. 2001; Wada et al. 2001; Osler and Bader 2004).  In 
contrast, we have reported that our original D033 polyclonal serum, while clearly 
reacting with the protein (Reese et al. 1999; Osler and Bader 2004), does not 
recognize Bves in heart muscle.  In addition to striated muscle staining, the SB 
antibody series recognizes Bves expression in some but not all smooth muscle 
populations.  Clearly, coronary smooth muscle is intensely stained by SB 
antibodies (Figure 9) in agreement with our previous polyclonal data. 
The major point of disagreement at this time concerning the expression of 
Bves is whether it is present in developing and adult epithelia. Using newly 
generated monoclonal antibodies, I was able to clearly demonstrate protein 
expression in many endodermally- and ectodermally-derived epithelia. Still, not 
all epithelia in the developing or adult organism exhibit antibody reactivity.  This 
may be due to variation in isoform production and/or the simple lack of 
expression. The localization of protein revealed by the SB1 antibody is highly 
similar to that observed using previously characterized mono- and polyclonal 
antibodies with the notable exception of epicardial staining. Additionally, our 
present studies definitively detect the protein in numerous cell lines of epithelial 
origin (Figure 7).  The subcellular distribution of Bves protein revealed by the SB 
series generally but not completely follows the pattern of staining observed with 
polyclonal B846 (Wada et al. 2001; Osler and Bader 2004). This staining is 
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abundant at points of cell-cell contact, consistent with the hypothesis that Bves 
plays a role in cell-cell adhesion/interaction (Wada et al. 2001; Osler and Bader 
2004). I have also observed Bves at points of myocyte-myocyte contact in 
reaggregation assays, which further supports this hypothesis. 
 The expression pattern revealed by investigation of Bves mRNA 
expression and lacZ knock-in is often different from the pattern revealed through 
examination of the protein expression.  Both in situ analyses (Andree et al. 2002) 
and lacZ knock-in assays (Andree et al. 2002) reveal very little epithelial 
expression.  However, three independently generated polyclonal antisera 
(against chick Bves, mouse Bves, and frog Bves) from our laboratory reveal Bves 
expression in a variety of epithelial tissues, along with striated and smooth 
muscle types.  In addition, the Duncan laboratory has generated a monoclonal 
antibody against chick Bves that also recognizes expression of Bves in the 
epicardium of the chicken at E6.  Examination of Bves expression in other 
epithelia using this antibody has not yet been published.  Still, the present data 
clearly detect Bves in a variety of epithelial cell types.  The discrepancy between 
mRNA expression analysis and analyses using immunoreagents may be due to a 
low level of Bves message in non-muscle cell types that makes mRNA detection 
difficult.  Accordingly, when using either immunochemical or riboprobe assays to 
determine expression of a protein, negative results should be interpreted 
cautiously as many factors can affect the results of these assays independent of 
message/protein presence. 
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 These antibodies clearly demonstrate that Bves is expressed in a variety 
of epithelial and muscular cell types, and that Bves protein expression extends to 
derivatives of all primordial germ layers.  Understanding of the expression pattern 
of the protein is necessary for developing and understanding the function of the 
protein.  Such broad expression within the organism and in species ranging from 
invertebrate to human indicates that the function of the Bves protein will likely be 
more general in nature, including muscle and non-muscle cell types. 
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CHAPTER III 
 
 
 
BVES INTERACTS WITH GEFT AND MODULATES RAC1/CDC42 SIGNALING 
 
 
 
Introduction 
 
Bves (blood vessel epicardial substance), a gene discovered by our 
laboratory in 1999, is widely expressed throughout development and adulthood in 
many different species.  All three developing germ layers (Osler and Bader 
2004), cardiac muscle (Reese and Bader 1999; Andree et al. 2000; DiAngelo et 
al. 2001; Hitz et al. 2002; Smith and Bader 2006), skeletal muscle (Andree et al. 
2000; Andree et al. 2002; Smith and Bader 2006), neural tissues (Andree et al. 
2000; Osler and Bader 2004), epicardium (Reese et al. 1999; Wada et al. 2001; 
Reese et al. 2002; Wada et al. 2003; Osler and Bader 2004; Vasavada et al. 
2004), epithelial components of the eye (Ripley et al. 2004), and smooth muscle 
(Osler and Bader 2004; Smith and Bader 2006) have all been demonstrated to 
express bves.  While expression of the Bves protein is now resolved, few 
definitive indications of molecular function exist.   
 Several indications of potential Bves function have been described.  
Epithelial integrity of cultured corneal cells is severely decreased by knockdown 
of Bves protein using morpholino oligonucleotides, possibly via an interaction 
with an interaction with a protein complex containing ZO-1 at the tight junction 
(Osler et al. 2005). Perturbation of Bves function has also been shown to disrupt 
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proper migration of epithelial components of the early Xenopus embryo (Ripley et 
al. 2006) and affect wound healing of epithelia in scratch assays (Ripley et al. 
2004).  Additionally, mice null for the bves gene are delayed in regeneration of 
skeletal muscle upon injury (Andree et al. 2002).  Despite these indications of 
Bves function, no direct molecular mechanism for any of these phenotypes exists 
at this time. 
 Many of the preliminary indications of Bves function seem to involve cell 
movement, interaction, and adhesion.  Using a yeast-two hybrid screen for 
interacting proteins, I identified GEFT (guanine nucleotide exchange factor T) 
(Guo et al. 2003) as a protein that interacts with the cytoplasmic portion of the 
Bves protein.  GEF proteins modulate activity of small GTPases, specifically the 
Rho family of GTPases in the case of GEFT (Guo et al. 2003; Bryan et al. 2004; 
Bryan et al. 2005; Bryan et al. 2006). The activity state of GTPases is controlled 
by GEFs and GAPs (GTPase-activating proteins).  GEFs stimulate exchange of 
GDP for GTP, thereby activating Rho-family small GTPases.  GAPs stimulate the 
activity of GTPases, thus favoring the inactive GDP-bound state of these 
proteins. The Rho-family of small GTPases have myriad effects on cell behavior; 
including control of proliferation, differentiation, cell motility, and gene expression 
(Bishop and Hall 2000; Etienne-Manneville and Hall 2002).  Considering 
previously observed organogenesis and cellular phenotypes observed when 
Bves function is inhibited, this relationship was examined further.   
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Here, I show that Bves interacts with GEFT.  I also demonstrate that 
transfection of a truncated version of Bves decreases Rac1 and Cdc42 activity, 
and that transfection of this Bves truncation or full-length Bves also decreases 
motility of NIH 3T3 cells in real-time assays.  This study provides evidence that 
Bves directly affects the activity levels of Rac1 and Cdc42, and that the 
phenotypes previously observed when Bves function is altered may be a result of 
modulation of Rho GTPase activity via a GEFT-Bves interaction.   
 
Materials and Methods 
 
Yeast two-hybrid  
The cytoplasmic portion (amino acids 115-358) of mouse bves was PCR 
amplified from a full-length mouse bves clone (aa 1–358) containing restriction 
sites and ligated into pGBKT7 for use in the Matchmaker Y2H System 3 (BD 
Biosciences Clontech, San Jose, CA) (Figure 13). The bait was mated with a 
yeast strain pretransformed with a mouse heart embryonic day 17.5 cDNA 
library. Yeast colonies that survived on Quadruple Dropout Medium (QDO; SD/–
Ade/–His/–Leu/–Trp/X-a-Gal) and exhibited lacZ expression were subjected to 
further testing. Colonies were streaked several times to ensure plasmid 
segregation. Library plasmids were isolated, and the inserts were sequenced by 
the Vanderbilt Sequencing Core Facility and identified using NCBI Blast (Altschul 
et al., 1990Go). For each identified protein product, false-positive tests involving 
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Figure 13:  Yeast two hybrid approach to isolation of Bves-interacting proteins.  The cytoplasmic carboxyl-terminus of 
mouse Bves (amino acids 118-358) were cloned into pGBKT7 via a PCR-based approach and transformed into yeast.  
This plasmid was then mated with a pretransformed E17.5 mouse heart library in a yeast two-hybrid screen.  Two 
independent clones were isolated that contained GEFT cDNAs
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empty vector and random protein matings were conducted to eliminate spurious 
interactions according to manufacturer’s recommendations. 
 
Deletion analysis 
 Deletion constructs of the bait used for the initial yeast two-hybrid screen 
were made by PCR amplification from the original bait plasmid, pGBKT7-mbves 
CT.  Deletion constructs of GEFT were generated by PCR amplification from 
pCMVTag-2b-mGeft (a kind gift from M. Liu) and cloned into pGADT7.  Deletion 
constructs generated are seen in Figure 14. Bves and GEFT deletion constructs 
were transformed into AH109 and Y187 yeast, respectively, for matings. Colonies 
were grown on QDO medium and tested for lacZ expression to determine viable 
interactions.       
 
Cell culture 
COS-7 cells were grown on 10-cm dishes and in DMEM (Cellgro).  Cells 
were transfected using Lipofectamine 2000 (Invitrogen) transfection reagent 
according to manufacturer’s specifications. Protein was extracted with 1 ml of 
extraction buffer (20 mM Tris pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-
100, 0.05% SDS, 1 mg/ml BSA, 1 mM DTT) and 100 µl of protease inhibitor 
(Sigma, P8340).  Extracted protein was subject to SDS/PAGE analysis followed 
by immunoblotting. Lysate (10 µg per lane) was used to confirm protein 
expression.  
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Glutathione bead preparation 
GST fusion proteins were generated by PCR from the C-terminal tail (aa 
115-347) and the N-terminal tail (aa 1-36) of murine Bves and cloned into the 
pGEX bacterial expression vector. GST-N terminal Bves, an ~34 kDa protein, 
consists of the GST tag 5' of the extracellular N-terminal region of Bves. GST-C 
terminal Bves, an ~66 kDa protein, contains the GST tag followed by the 
intracellular C-terminal tail of Bves. Constructs were transformed into BL21 E. 
coli bacterial strain and protein was induced with isopropyl-ß-D-
thiogalactopyranoside (IPTG) using standard methods (Amersham). Bacterial 
lysates were prepared by 5 cycles of freeze/thaw, followed by brief sonication, 
and were stored at –80°C until use.  
Preparation of glutathione-Sepharose 4B for pull-down was performed as 
follows. A 50% slurry of glutathione-Sepharose 4B was prepared from a 
commercially available 75% slurry (Amersham). An aliquot of 1 ml of bacterial 
lysate expressing the GST fusion proteins was cleared by centrifugation (14,000 
g) prior to the addition of 40 µl of 50% slurry. Cleared lysate was incubated with 
glutathione-Sepharose 4B for at least 2 hours; the Sepharose was then washed 
three times with 100 µl of PBS, and resuspended in 100 µl of PBS.  These 
glutathione-Sepharose 4B beads, now bound to the GST, GST N-terminal Bves, 
or GST C-terminal Bves, were used for interaction assays described below.  In 
order to verify that the amounts of glutathione-Sepharose 4B-bound GST proteins 
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being used for pulldown experiments was consistent, 20 µL samples of these 
reagents were boiled in 2x SDS-PAGE sample buffer, and eluted proteins were 
subjected to SDS-PAGE followed by colloidal blue staining.  
 
GST-pulldown of GEFT 
Mouse GEFT was amplified from pCMVTag-2b-mGeft and cloned in frame 
with GFP of pEGFP-C1 (Clontech) to generate pEGFP-mGeft.  pEGFP-mNudeL1 
was generated previously by our laboratory (Soukoulis et al. 2005).   
COS-7 cells transfected with pEGFP-mGeft or pEGFP-mNudeL1 were 
grown to confluence in 10-cm dishes. Protein was extracted with 1 ml of 
extraction buffer (20 mM Tris pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-
100, 0.05% SDS, 1 mg/ml BSA, 1 mM DTT) and 100 µl of protease inhibitor 
(Sigma, P8340). Cells were incubated on ice for 30 minutes with gentle agitation, 
scraped off the plate and centrifuged for 30 minutes at 18,000 g at 4°C. Cell 
lysate was removed from the pellet and retained.  
Lysate was precleared by incubation with 20 µl bed volume of glutathione-
Sepharose 4B for 2 hours at 4°C, after which beads were spun down and lysate 
was removed. Glutathione-Sepharose 4B bound with GST constructs was then 
added to the lysate and incubated overnight at 4°C.  Sepharose conjugates were 
captured using centrifugation, washed 5 times with 100 µl PBS and bound protein 
was eluted with 20 µl of 1x SDS sample buffer, boiled for 3 minutes, and loaded 
onto an 10% SDS-PAGE gel. Western blotting was performed using standard 
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methods and the antibody concentrations used were as listed below. Blots were 
developed by using nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate 
(Roche) and scanned into digital format (Hewlett–Packard). 
 
Antibodies 
 Monoclonal anti-GFP (JL8, Invitrogen) was used at a dilution of 1:5000; 
monoclonal anti-Rac1 (Abcam) and polyclonal anti-Cdc42 (Abcam) were used at 
1:500 dilutions according to manufacturers directions.  Appropriate alkaline-
phosphatase conjugated antibodies (Sigma) were used at 1:30,000 dilutions for 
immunoblotting. 
 For immunostaining, monoclonal antibodies to Bves (Smith and Bader 
2006) were used at a 1:2000 dilution.  Polyclonal antibody against the GEFT 
protein (a kind gift of M. Liu) was used at a 1:1000 dilution.  Secondary detection 
was performed using Alexa-568 and Alexa-488 conjugated specific antibodies 
specific to the primary antibodies used. 
  
Rac1/cdc42 activation assay 
 COS-7 cells were transfected as described with pEGFP-C3 vector and 
pEGFP-mBvesCT-myc (aa115-aa358) expression vectors.  Cells were then 
harvested in MLB (Magnesium-containing Lysis Buffer) two days after 
transfection, lysates were sonicated for five seconds, centrifuged for 30 minutes 
at 18,000 g at 4°C following manufacturer’s specifications for Rac1/Cdc42 Assay 
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Reagent Kit (Upstate Cell Signaling) (Taylor and Shalloway 1996).  10 µg of 
Rac1/Cdc42 assay reagent was added to 600 µL of protein lysate, and gently 
rocked at 4°C for 30 minutes.  PAK-21-agarose conjugates were collected by 
centrifugation for 5 seconds at 14,000 g at room temperature, washed 3x with 
500 µL MLB, and bound protein was eluted in 25 µL SDS-PAGE sample buffer.  
Western blotting of these samples, and of 10 µL of the original lysate as a 
loading control, was performed using standard protocols.  
 
Motility assays 
The intracellular C-terminus of Bves (aa115-358) was cloned into a 
mammalian expression construct (pCMV-myc).  Full length Bves was cloned in 
frame with GFP of the pEGFP-C1 plasmid to generate GFP-Bves.  NIH 3T3 cells 
were cotransfected using Lipofectamine 2000 at 95% confluency with pCMV-
myc-BvesCT and pEGFP-C1 (as a tracer for transfected cells), GFP-Bves, or 
with pEGFP-C1 alone.  Cells were split to ~10% confluency two days after 
transfection.  Initial assays of cell motility analyzing the effects of full length Bves 
transfection were performed by the Lo laboratory at the National Institutes of 
Health as described previously (Xu et al. 2006).  For monitoring the velocity of 
cell motility (total path length/time), cells in 10 cm2 dishes were placed on the 37° 
heated stage of a Leica DMIRE2 inverted microscope.  Time-lapse images were 
captured using an Orca-ER camera.  Images were captured every 60 seconds 
over a 45 minute interval using a 10x objective.  Quantitative motion analysis was 
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carried out using Dynamic Image Analysis Software (Solltech, Oakdale, IA).  The 
outline of each cell was traced frame by frame, and using these tracings the 
DIAS software calculated the speed of cell movement by tracking the change in 
position of the cell centroid for each frame.  All data from these experiments were 
evaluated by ANOVA using Statview (SAS Institute, Cary, NC). 
Experiments evaluating the effects of exogenous expression of the 
carboxyl-terminus of Bves were conducted at the Cell Imaging Shared Resource 
at Vanderbilt University.  Cells were transfected as described, and split to ~10% 
confluence in 24-well culture plates (Nalgene).  Plates were placed on the 37° 
heated stage of a an inverted Nikon TE300 widefield microscope with automated 
stage for acquisition of multiple fields or view.  Images were captured every two 
minutes for 30 minutes using a 20x objective.  Quantitative motion analysis was 
carried out as described above using Metamorph software (Molecular Devices, 
Sunnyvale, CA).  Data was evaluated using Microsoft Excel. 
 
Cell roundness assay 
 In addition to the motility data rendered from the analysis of exogenous 
expression of GFP-Bves described above, the cell tracings were also used to 
investigate the relative roundness of cells transfected with either GFP-Bves or 
GFP alone.  The roundness of these cells was calculated using the equation 100 
X 4π (area/perimeter2) (Stites et al. 1998).  This equation provides a 
measurement of how efficiently a given amount of perimeter encloses area:  a 
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circle has the largest area for any given perimeter with a roundness of 100%.  
Accordingly, the greater the number of cell protrusions, the lower the roundness.  
All data obtained from quantitative assessments were evaluated by ANOVA 
using Statview as above.        
 
Results 
 
The cytoplasmic C-terminus of Bves interacts with GEFT. 
A yeast two-hybrid screen was used to isolate Bves interacting proteins 
from an embryonic mouse heart library (Figure 13).  The cytoplasmic carboxyl 
terminal portion of Bves (aa115-358) was used for this screen.  This region of 
Bves contains the uncharacterized popdc domain (Breher et al. 2004; Brand 
2005; Osler et al. 2006).  Utilizing a yeast two-hybrid screen with cDNAs 
expressed in the embryonic mouse heart, I isolated 104 interacting proteins when 
the carboxyl-terminus (aa115-aa358) of mBves was used as bait. Two 
independent clones were isolated that contained coding sequence for amino 
acids 46-344 of the mouse GEFT protein.  Both of these clones passed the false 
positive screening process.  As previous experiments have shown defects in cell 
motility/interaction (Ripley et al. 2004; Osler et al. 2005; Ripley et al. 2006), I 
chose to pursue this interaction further. 
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Deletion analysis of interacting domains 
In order to determine which regions of the Bves and GEFT proteins were 
responsible for the interaction revealed by the yeast-two hybrid screen, a deletion 
analysis further utilizing the yeast-two hybrid method was used.  A series of 
truncations of the cytoplasmic portion of Bves revealed that the portion of the 
protein between amino acid 250 and amino acid 300 is critical for interaction with 
GEFT (Figure 14).   
 The truncation analysis to determine the region of the GEFT protein 
responsible for interaction with Bves revealed that the portion of the protein 
between amino acid 300 and amino acid 450 is necessary for interaction with 
Bves (Figure 14).  However, further analysis of the results of these studies 
revealed that these regions (aa 250-aa 300 of Bves, aa 300-aa 450 of GEFT) are 
necessary, but not sufficient for the Bves-Geft interaction to occur as neither aa 
250- aa 300 of Bves or aa 300- aa450 of GEFT interacts with the other full-length 
interacting partner.    The cytoplasmic portion of Bves has previously been shown 
to contain cysteines through which intramolecular disulfide binding occurs (Knight 
et al. 2003).  The region of Bves shown here to be responsible for interaction with 
GEFT contains a cysteine at amino acid 283, indicating that an intramolecular 
disulfide bond through this cysteine may be critical for Bves protein structure that 
dictates interaction with GEFT.  It should also be noted that the Dbl homology 
(DH) domain (Hoffman and Cerione 2002), which is the domain of GEFT 
responsible for nucleotide exchange activity with GTPases, falls within the region  
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Figure 14:  Deletion analysis strategy.  Bves and GEFT truncations were 
generated using PCR-based strategies for further definition of interacting 
domains.  Bves truncations (black bars) were screened against full-length GEFT 
(aa34-618) for interaction.  GEFT truncations (gray bars) were screened against 
aa118-358 of Bves.  Results of matings listed on right, + signifies growth on 
selective media, while – indicates no growth observed upon mating. 
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that I have found to be necessary for GEFT-Bves interaction.  This domain is 
present in all Dbl family members, and our findings may indicate that Bves is 
capable of interaction with other Dbl family members.  Our laboratory is currently 
investigating this possibility.  Taken together, the data presented here 
demonstrate that the aa 250-aa 300 region of Bves and the aa 300-450 region of 
GEFT are necessary for the interaction between these two proteins. 
 
Biochemical verification of mBves-mGeft interaction 
 Utilizing a GST-pulldown strategy, I biochemically confirmed the Bves-Geft 
interaction revealed by the genetic screen.  Prokaryotic GST-fusion protein 
expression constructs of Bves were generated, while GEFT-GFP fusion protein 
expression plasmids were generated for use in mammalian cells.  COS-7 cells 
were transfected with the GEFT-GFP expression plasmid, protein was harvested 
and incubated with GST-mBves Sepharose.  Figure 15 demonstrates that mBves 
specifically pulls down GEFT protein while no interaction is detected using GFP-
NudeL protein as a negative control.  NudeL is a microtubule-binding protein 
unrelated to Bves function (Liang et al. 2004; Li et al. 2005).  Thus, I demonstrate 
that mBves specifically interacts with mGeft in this assay and corroborate the 
yeast two-hybrid analyses.   
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Figure 15:  GST-Bves pulldown of GEFT.  GST-Bves fusion proteins representing 
the extracellular N-terminus and cytoplasmic C-terminus of Bves were tested for 
interaction with GEFT-GFP and NudeL-GFP (Figure 15A).  Representative 
mobilities of mGeft-GFP (Figure 15B, lane 1) and mNudeL-GFP (Figure 15B, 
lane 2) are provided.  No reactivity is observed in lanes containing isolates from 
GST/mGeft-GFP (Figure 15B, lane 3), GST-mBves1-22/mGeft-GFP (Figure 15B, 
lane 4), or GST-mBves 115-358/mNudeL-GFP (Figure 15B, lane 6) pulldowns, 
indicating these proteins do not interact.  A band representing mGeft-GFP is 
clearly seen in the lane containing isolate from the GST-mBves115-358/mGeft-
GFP pulldown. 
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Exogenous expression of mBves affects activation of Rac and cdc42. 
 Having demonstrated that mBves interacts with mGeft, I next sought to 
determine if mBves expression changes activity levels of the Rac1 and Cdc42 
GTPases.  As the PAK-21 protein binds to only activated (GTP-bound) forms of 
active GTPases (Benard et al. 1999; Chiang et al. 2001), I utilized a PAK-21 
pulldown approach to assay for GTPase activity upon transfection of mBves 
constructs.  NIH 3T3 cells were transfected with pEGFP-mBvesCT-myc or 
pEGFP-C3 vector as a control.  Lysates were harvested and subjected to PAK-
21 pulldown.  Amounts of GTP-bound Rac1, Cdc42, and RhoA were determined 
by SDS-PAGE followed by immunoblotting using published methodologies.  
Whole cell lysates from each sample were also immunoblotted to verify that 
similar amounts of protein were used for each pulldown experiment, and each 
assay was performed in triplicate.  As seen in Figure 16, transfection of mBves-
CT markedly reduces the amount of active Rac1 and Cdc42 while the amount of 
active RhoA remains unchanged.  As GEFT has previously been shown to bind 
and preferentially activate Rac1 and Cdc42 as opposed to RhoA (Guo et al. 
2003), this result is consistent with Bves modulation of Rho-family GTPase 
activity through an interaction with GEFT. 
 
mBves decreases movement speed of NIH 3T3 cells and increases cell 
roundness 
 
 Having determined that expression of the intracellular carboxyl terminus of  
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Figure 16:  Transfection of the carboxyl-terminus of Bves reduces Rac1 and 
Cdc42 activity in NIH 3T3 cells.  Cells were transfected with either pEGFP 
(control) or pEGFP-BvesCT (amino acids 118-358 of mouse Bves).  Lysates 
were harvested, and PAK-21 pulldowns were performed.  Samples from 
pulldowns were loaded and blotted with α-Rac1, α-Cdc42, and α-RhoA 
antibodies to determine relative amounts of isolated active proteins.  Amount of 
isolated Rac1 and Cdc42 is significantly reduced upon truncated Bves 
expression, while amount of active RhoA appears unchanged.  Cell lysates were 
loaded and blotted with α-Rac1 to verify equivalent amounts of total Rac1 was 
present in samples used for assay. 
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 Bves reduces the amount of active Rac1 and Cdc42 in NIH 3T3 cells, I next 
sought to determine if transfection of full-length Bves and truncated Bves has an 
effect on cellular motility.  Previous studies have determined that reduction of 
Rac1 and Cdc42 activity results in a decrease in cell movement (Kraynov et al. 
2000; Etienne-Manneville and Hall 2001; Itoh et al. 2002).  Co-transfection of a 
GFP marker plasmid with the carboxyl terminus of GFP, or transfection of full-
length murine Bves fused with GFP allowed real-time imaging of cell movement 
in collaboration with the Lo lab at the National Institutes of Health.  As seen in 
Figure 17, transfection of the full-length mBves-GFP construct markedly (~45%) 
reduces the speed of cellular migration (total path length/time) (Figure 17) in 
comparison to the control cells which were transfected with a GFP-only 
expression plasmid. As Rac1 and Cdc42 signaling are well-characterized 
activators of cellular motility (Etienne-Manneville and Hall 2002), this decrease in 
cell movement would be expected due to the previously observed decrease in 
active Rac1 and Cdc42 (Figure 16).  No significant change in directionality of 
movement (net path length/total path length) was detected in this experiment 
(data not shown). 
 These experiments also allowed us to analyze the effect of exogenous 
Bves expression on cellular roundness. Using the measured area and perimeter 
length of a cell, it is possible to quantify how efficiently the measured perimeter 
encompasses the cellular area.  The maximum roundness measurement would 
be obtained from a cell that was perfectly circular.  Therefore more protrusions 
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Figure 17:  Transfection of Bves and truncated Bves reduces motility of NIH 3T3 
cells.  Cells were transfected and motility measured as described in Materials 
and Methods.  Upon transfection of either full-length (green bar) or truncated 
Bves (aa 118-358, red bar), a significant reduction in motility speed is observed 
in comparison to cells transfected with a GFP-only expressing plasmid (blue 
bars).  Error bars represent SEM, significance determined using standard 
Student-T test. 
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 (lamellipodia and filopodia) a cell has, the lower the cell’s measured roundness 
will be.  As Rac1 and Cdc42 drive lamellipodial and filopodial extension (Fukata 
et al. 2003), respectively, cells with higher levels of active Rac1 and Cdc42 would 
have lower roundness measurements than cells with relatively lower levels of 
active Rac1 and Cdc42.  Consistent with our previous findings that exogenous 
Bves expression negatively regulates the amount or active Rac1/Cdc42, this 
experiment found that exogenous expression of Bves caused cells to be ~25% 
more round than cells transfected with a GFP marker plasmid alone (Figure 18).  
Again, this indicates that overexpression of Bves leads to a repression in overall 
Rac1/Cdc42 signaling activity.    
Subsequent experiments conducted at Vanderbilt by our laboratory further 
support our findings.  As shown in Figure 17, cotransfection of the carboxyl 
terminus of mBves with a GFP marker plasmid also decreases the rate of cell 
movement in this assay by ~22% in comparison to cells transfected with the 
marker plasmid alone.  Taken together, these findings demonstrate that 
exogenous expression of full-length Bves or the cytoplasmic carboxyl-terminus of 
Bves negatively regulates cell movement.  
 
Discussion 
Bves is a protein expressed in a variety of tissue types throughout 
development.   It has previously been demonstrated that Bves affects the trans- 
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Figure 18:  Transfection of truncated Bves decreases protrusive activity.  Roundness of cells 
measured in real-time as described in Materials and Methods.  Software analysis of cellular area 
and perimeter allows determination of roundness (sample of images rendered for analysis 
presented in top panels).  Upon transfection of truncated Bves (aa118-358), an increase in 
roundness (red bar) of ~25% is observed in comparison to cells transfected with GFP only (blue 
bar). ).  Error bars represent SEM, significance determined using standard Student-T test. 
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epithelial resistance of cultured cells, possibly via an interaction with a protein 
complex containing the tight junction protein ZO1. Several other phenotypes 
have been reported when Bves protein is decreased, but no molecular 
mechanism for these observations has been determined to this point.  The 
presented data are the first to establish a direct interaction with any protein and 
link Bves to an established molecular pathway.  
Upon knockdown of Bves expression in gastrulating Xenopus laevis, 
defects in epithelial morphogenesis and cell movements have been observed 
(Ripley et al. 2006). Global inactivation of the murine Bves gene leads to defects 
in skeletal muscle repair by satellite cells (Andree et al. 2002), and upon 
knockdown of Bves expression in cultured epithelia defects in wound healing 
have also been reported (Ripley et al. 2004).  The described interaction with a 
component of the Rac1/Cdc42 signaling pathway may provide the first molecular 
mechanism to explain the cellular/embryonic phenotypes observed upon 
alteration of Bves expression levels previously described in the literature.  
 
Bves interacts with GEFT, a modulator of Rho-family GTPase signaling 
Here, I demonstrate that Bves interacts with GEFT, a GEF for small Rho-
family GTPases.  GEFT has previously been shown to affect cell proliferation, 
foci formation (Guo et al. 2003), neurite outgrowth (Bryan et al. 2004; Bryan et al. 
2006), differentiation, and skeletal muscle regeneration (Bryan et al. 2005); 
presumably through modulation of Rho-family GTPase activity.  The motility of 
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cells has been shown in numerous studies to be controlled by Rho-family 
GTPases through the control of processes such as filopodial and lamellipodial 
extension, as well as polymerization of actin (Etienne-Manneville and Hall 2002).  
Here, I show that when wildtype Bves or a Bves truncation is transfected into NIH 
3T3 cells, movement and roundness of these cells is dramatically affected. I also 
show here that exogenous overexpression of truncated Bves reduces the amount 
of active Rac and Cdc42 when expressed in NIH 3T3 cells.  These results 
support our hypothesis that Bves modulates the Rac1/Cdc42 activity through an 
interaction with GEFT.  Potential models for the experimental results presented 
here are discussed later in this chapter. 
 
Modulation of Rac1/Cdc42 activity by Bves is consistent with observed Bves 
knockdown/knockout phenotypes  
 
Control of GTPase activity via an interaction with GEFs could provide an 
explanation for previously observed phenotypes that currently lack mechanistic 
explanation. Numerous studies have demonstrated the critical role for 
Rac1/Cdc42 during gastrulation and convergent extension of Xenopus (Habas et 
al. 2003; Tahinci and Symes 2003; Miyakoshi et al. 2004; Kwan and Kirschner 
2005; Ren et al. 2006).  Our laboratory previously described a defect in epithelial 
migration upon knockdown of Bves expression using morpholino oligonucleotides 
on developing Xenopus embryos. Perturbation of Rac1/Cdc42 activity by Bves 
knockdown would seem a plausible explanation for this phenotype.   
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Similarly, previous work has shown that knockdown of Bves expression in 
cultured corneal epithelial cells disrupted epithelial integrity and delayed healing 
of epithelial sheets upon wounding via scratch assay.  Rac1 and Cdc42 have 
been shown to be critical players in cellular activity required for wound healing 
and epithelial sheet integrity (Fenteany et al. 2000; Nobes 2000; Kofron et al. 
2002; Malliri et al. 2004; Stramer et al. 2005; Woolner et al. 2005; Kimura et al. 
2006).  Again, the phenotypes observed upon disregulation of normal Bves levels 
are consistent with a role for Bves in control of Rac1/Cdc42 signaling. 
Additionally, the Brand laboratory noted that in Bves-null animals, skeletal 
muscle regeneration is delayed upon injury.  Rac1/Cdc42 has been shown to 
affect skeletal muscle regeneration (Chen et al. 2003; Bryan et al. 2005) and 
regeneration is dependent on process extenstion and myoblast motility (Carlson 
1973; Carlson and Faulkner 1983). This previously observed phenotype is also 
seemingly consistent with a role for Bves in control of Rac1/Cdc42 signaling. 
 
Potential mechanisms of Bves modulation of Rac1/Cdc42 activity 
 The discovery of an interaction between Bves and GEFT leads us to 
several potential models for Bves function.  Future investigations by our 
laboratory will attempt to determine which, if any of these current models 
represent the actual mechanism through which Bves generates the previously 
observed phenotypes.  Several other questions are brought to light by our 
discovery of this interaction, including the question of whether Bves interacts with 
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other GEFs, or is an interacting protein specific to GEFT.  If it is determined that 
Bves does interact with other GEFs, the interaction presented here may 
represent an entirely new pathway for cellular regulation of GTPase activity. 
 The first potential model is one where Bves controls the nucleotide binding 
ability of GEFT, and possibly other GEFs.  As shown previously, Bves 
preferentially localizes to the plasma membrane (Wada et al. 2001; Osler et al. 
2005; Smith and Bader 2006).  GEFT contains a pleckstrin homology domain 
(PH), which has been demonstrated to localize Dbl family GEFs to the membrane 
(Russo et al. 2001; Vanni et al. 2002).  As demonstrated here, the intracellular 
carboxyl terminus of Bves interacts with the DH domain of GEFT, which is the 
portion of GEFT responsible for interaction with the nucleotide-binding pocket of 
GTPases.  This GEF-GTPase interaction leads to a conformational change in the 
nucleotide-binding pocket of the GTPase, which stimulates GDP release 
(Rossman et al. 2002).  A Bves-GEF interaction may serve as a negative 
regulator of GEF activity, thereby leading to decreased activation of GTPase 
signaling.  Thus, the overexpression of truncated or full-length Bves may lead to 
aberrant blockage of this active site, causing the experimental results presented 
here.  This model is also consistent with previously reported “Bves-knockdown” 
phenotypes of delay in skeletal muscle regeneration, aberrant cell movement 
during Xenopus gastrulation, and altered epithelial sheet integrity and migration.  
If Bves controls the nucleotide binding activity of GEFT and potentially other 
 84 
GEFs, disregulation of GTPase signaling control would likely result, potentially 
generating the previously published phenotypic abnormalities. 
Another potential model for Bves regulation of GTPase signaling through 
GEFT interaction is one in which Bves controls the proper localization of GEFT to 
active sites of GTPase activity.  As Rac and Cdc42 activity have been previously 
reported to be highest at the leading edges of motile cells (Etienne-Manneville 
and Hall 2002), proper localization of GEF proteins to the plasma membrane in 
these areas is critical for proper control of cellular motility.  Bves may serve to 
localize GEFT (and potentially other GEFs) to this leading edge, allowing them to 
catalyze nucleotide exchange of GTPases (Figures 19 and 20).  This model is 
also consistent with the results described here.  Exogenous overexpression of 
full-length and truncated Bves may disrupt this controlled localization, resulting in 
a decrease in overall GTPase activity at the leading edge due to decreased GEF 
presence in the area.  As transfected full-length Bves has been reported to 
accumulate in the Golgi/ER and not localize to the membrane (Knight et al. 
2003)(Smith and Bader unpublished results) and the truncated Bves used here 
has a broad cytoplasmic distribution (Smith and Bader 2006), exogenous 
expression of these proteins could serve as a “sink” that prohibits localization of 
GEFT to the leading edge of motile cells.  Again, this model is also consistent 
with the previously observed knockdown/inactivation phenotypes.  If Bves is 
critical for proper localization of GEFT and possibly other GEFs to sites of 
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Figure 19:  Potential model for Bves function.  In a normal cell, Bves acts as a 
“scaffolding” protein, facilitating interaction with membrane-associated GTPases 
with GEFT (Figure 20A),  However, when either full-length (Figure 20B) or 
truncated Bves (not shown) is exogenously expressed, GEFT may be 
sequestered from the site of activity at the membrane. 
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Figure 20:  Potential model for Bves function.  In a normal cell, Bves normally 
acts to sequester GEFT from interacting with membrane-associated GTPases 
(Figure 21A).  A signal from the cell stimulates release of GEFT, and GEFT then 
moves to the membrane and interacts with GEFT causing stimulation of GTPase 
activity.  When full-length or truncated Bves is exogenously expressed (Figure 
21B), aberrant interaction of Bves and GEFT leads to improper localization of 
Bves, and overall repression of GTPase activity. 
 87 
 
activity, decreased Bves levels would disregulate GTPase signaling cascades 
through improper localization of the necessary catalytic proteins.   
 Similarly, Bves may block interaction of GEFT and potentially other GEFs 
with another protein(s) at the plasma membrane that are necessary for proper 
localization of GEFs during GTPase activation. Bves may serve to block 
interaction between GEFs and membrane anchors during times when 
Rac1/Cdc42 activity is downregulated. Accordingly, this blockage would then be 
somehow removed during periods of GTPase activity upregulation. 
Overexpression of the proteins used in these experiments may block these GEF-
anchor protein interactions from occurring, leading to an overall decrease in 
GTPase activity due to improper localization of GEFT.  As with the previously 
described models, this model is also consistent with results observed upon 
depletion of Bves protein.  Decreased Bves protein in a cell in this model would 
allow GEFT and possibly other GEFs to be constantly available for stimulation of 
GTPase activity, and lead to overall deregulation of the tightly controlled GTPase 
signaling cascades necessary for proper control of cellular movement.   
 In summation, I have determined that Bves interacts with GEFT, a 
member of the Dbl family of GEFs.  I report that exogenous expression of full-
length and truncated Bves constructs in vitro leads to a decrease in active levels 
of Rac1 and Cdc42, and results in phenotypic changes consistent with 
downregulation of Rac1 and Cdc42 activity.  This represents the first direct 
molecular interaction elucidated for the Bves protein, and provides the first and 
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only current link to a characterized cellular pathway.  The results presented here 
are consistent with previously observed phenotypes in other experimental 
systems, and provides direction to the fields continuing investigation of the 
function of Bves. 
 
Current Investigations 
 Investigation of the Bves-Geft interaction is still underway in our 
laboratory.  We are currently attempting to determine the colocalization of GEFT 
and Bves in a variety of tissues and cell types using confocal microscopy.  I have 
examined the localization of both the GEFT and Bves proteins in differentiated 
C2C12 myoblasts (Figure 21).  In this cell type, I have not observed extensive 
colocalization of Bves and GEFT to this point.  This result is not necessarily 
inconsistent with the previously presented data, however.  As localization of 
these proteins changes during different cellular events, we will likely need to 
assay a variey of cell lines undergoing different cellular processes to determine at 
what time and place Bves and GEFT colocalize, and subsequently determine the 
localization of these proteins.  For example, in two different myotubes shown in 
Figure 19, different protein localizations are observed.  A significant portion of the 
protein is seen to be cytoplasmic in distribution (white arrowheads) in some 
areas.  In other areas, very little cytoplasmic Bves is seen, and the vast majority 
of the Bves protein localizes to the plasma membrane of the cell (white arrows).   
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Figure 21:  Localization of Bves and GEFT in differentiated C2C12 myotubes.  
Differentiated C2C12 myotubes were labeled with antibodies against GEFT 
(green) and Bves (red).  Confocal microscopy was used to examine the 
localization of these proteins in a three dimensional manner.  Bves is observed to 
localize to both the intracellular space (arrowheads), and also to be enriched at 
the plasma membrane surrouding myotubes (arrows). 
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CHAPTER IV 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Conclusions 
 
Summary 
 Bves was isolated by the Bader lab in 1999, and has since been the 
subject of more than 20 peer-reviewed articles.  As with many recently 
discovered molecules, the earliest work on Bves was centered on defining the 
genomic organization of the bves gene.  Subsequent work focused on the 
definition of expression of bves in the chicken and mouse.  The two groups 
actively studying Bves at this time, the Brand group and the Bader group, utilized 
two different methodologies for analysis of Bves expression.  The Brand group 
focused on definition of Bves expression using protocols that defined the 
presence of bves message, and reported bves was expressed nearly exclusively 
in striated muscle and non-vascular smooth muscle.  Our group chose to 
examine Bves expression using immunoreagents, and generated polyclonal 
antibodies against the chicken Bves protein.  Using these antibodies, the Bader 
group found Bves to be expressed in the proepicardium, epicardium, and 
components of the coronary vasculature.  Interestingly, these reagents also 
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indicated that Bves is expressed in multiple epithelia throughout the embryo such 
as the gut and eye.      
 These divergent findings led to an important question in the Bves field.  
While the Bader group focused on studying Bves in the developing coronary 
vasculature, the Brand group directed their efforts towards analysis in striated 
muscle types.  In fact, the expression of Bves in epithelial cell types has been the 
center of disagreement since the initial publications describing Bves.  While 
immunochemical detection methods showed the presence of Bves in epithelial 
cell types as well as striated muscle, examination of Bves expression using RT-
PCR, in-situ hybridization, and northern blotting showed that Bves was 
expressed only in striated and non-vascular smooth muscle. 
 Definition of the domain of expression of a gene is a critical step in its 
study.  The knowledge of where a protein is expressed and where it is absent 
provides clues to potential function.  For example, knowing that a protein is 
expressed only in muscle cell types would indicate that this protein might have a 
“muscle-specific” function.  Likewise, knowing that a protein is absent from 
certain cell types allows exclusion of some possible functional hypotheses.  
Accordingly, I sought to properly define the expression pattern of Bves using 
newly developed monoclonal antibodies to the Bves protein.  The results 
presented in Chapter II of this dissertation conclusively demonstrate that Bves is 
expressed not only in striated muscle and some non-vascular smooth muscle, 
but is also expressed in multiple epithelial cell types throughout the developing 
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mouse embryo as well as vascular smooth muscle of the coronary vasculature 
(Smith and Bader 2006).  These findings are critical for the analysis of Bves, as 
they not only resolve the persistent conflict in the literature, but also indicate that 
Bves likely has a function that is not specific in nature to muscle.   
However, the most important question in the Bves field still had no answer:  
What is the molecular function of Bves?  As Bves contains no conserved protein-
protein interaction motifs, and appears to have been subject to gene duplication 
during evolution (Andree et al. 2000; Brand 2005), candidate or inactivation 
approaches were excluded from consideration by our laboratory.  Early in this 
project, I developed the hypothesis that determining the protein(s) that interact 
with Bves will reveal the function of Bves.  I reasoned that being able to place 
Bves into a molecular pathway would enable us to postulate about Bves function 
in a more focused manner, and directly test these hypotheses to determine the 
functional significance of the Bves protein.  To this end, I conducted a yeast two-
hybrid screen to find interacting protein(s), and isolated GEFT.  As described in 
Chapter I, GEFT modulates Rho-family GTPases.  In Chapter III, data was 
presented that clearly demonstrates that Bves biochemically interacts with GEFT.  
I also presented data that Bves overexpression in vitro represses Rac1 and 
Cdc42 activation, and also produces cellular phenotypes consistent with 
modulation of Rho-GTPase signaling.   
Thus, the data presented in this thesis not only resolve important 
questions in the literature concerning the expression pattern of Bves, but also 
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describe the first direct molecular interaction with another protein.  In addition, 
modulation of a defined cellular signaling pathway has been demonstrated, 
placing Bves into a molecular context that will enable the entire field to more 
directly examine the molecular function of this novel protein.  The following 
discussion addresses several points about the previously presented data, and 
discusses several potential models of function along with experiments to 
investigate these models. 
 
The importance of Bves expression in non-muscular tissues 
 The generation of the monoclonal α-Bves immunoreagents described in 
Chapter II is an important event in the field of Bves study.  Before the publication 
of this work, dispute about the localization of Bves was one of the primary topics 
in the literature of the field.  Expression studies using polyclonal antibodies 
clearly showed expression in non-muscle cell types (Reese and Bader 1999; 
Reese et al. 1999; Wada et al. 2001; Osler and Bader 2004; Ripley et al. 2004; 
Vasavada et al. 2004).  However, some of these antibodies were not reactive 
with mammalian forms of the protein, and all were beginning to be in short supply 
due to their polyclonal nature.  To address these issues, I generated a panel of 
monoclonal reagents against the mouse Bves protein and conducted an assay of 
expression during mouse embryogenesis that clearly demonstrates widespread 
non-muscular expression of Bves (Smith and Bader 2006).  In the literature at 
this point, there are 3 unique polyclonal antisera (Reese et al. 1999; Wada et al. 
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2001; Ripley et al. 2004), one monoclonal against avian Bves (Vasavada et al. 
2004), and the antibodies described in Chapter II.  All of these antibodies 
recognize Bves in non-muscular cell types. 
 While the antibodies described in Chapter II do not recognize Bves in 
either of these structures at the developmental stages examined, they clearly 
label Bves in the smooth muscle of the coronary vasculature of the mature heart. 
It should be noted that the antibodies described in Chapter II recognize Bves in 
the EMC (Epicardial Mesenchymal Cell) line, which is a cell line derived from 
epicardium.   Additionally, all 5 of the antibodies I generated and described in 
Chapter II recognize Bves in a variety of epithelial cells lines and epithelia in 
developing and mature organisms.  A more thorough investigation of the 
expression of Bves in the epicardium is still needed to determine if the antibodies 
developed here recognize Bves in the epicardium at other stages than those 
examined, but it is clear from the data presented that Bves is expressed in 
multiple epithelial tissues and in coronary smooth muscle, which is a product of 
the proepicardium/epicardium.  
 Beyond the knowledge of where and when a protein is expressed, 
determining the localization pattern of a protein is important for other reasons.  
For instance, expression of a protein can serve to mark a specific population of 
cells for experimental purposes.  For example, the protein Sca-1 is commonly 
used to identify hematopoietic stem cells in a variety of experimental protocols 
(Spangrude et al. 1988; Spangrude et al. 1989).  Using this marker, investigators 
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can isolate populations stem cells or study the localization and activity of these 
cells in vivo.  Similarly, expression of Bves is now used in the field of coronary 
vessel development as a marker for the epicardium or epicardially-derived cells.  
More importantly for this discussion, however, is how the expression pattern of 
Bves can be used to hypothesize about the function of the protein itself.  If Bves 
were found to be muscle-specific, it would naturally lead an investigator to 
hypothesize that the protein might have a role in contraction, fusion of myoblasts, 
or regulation of muscle-specific genes.  However, understanding that Bves is 
actually expressed in a variety of non-muscle cell types, as well as striated 
muscle, they would likely be led to a different set of possible hypotheses when 
considering the function of the protein.  The finding that the Bves protein was not 
specific to striated muscle led us to hypothesize that Bves must play a role in a 
process conserved between epithelial and muscular cell types. 
  
Bves interacts with GEFT, a modulator of Rho-GTPase signaling 
 In Chapter III, I describe the discovery and characterization of an 
interaction between Bves and the Rac1/Cdc42 specific GEF GEFT.  As this 
protein-protein interaction was isolated using yeast two-hybrid technology, by 
nature of the experimental method the interaction between GEFT and Bves is 
direct.  This is the first reported direct interaction of Bves with any protein, and 
thus represents a major landmark in the study of the Bves.  I also present data 
from cell culture models consistent with Bves modulation of Rac1/Cdc42 control.  
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While there have been several phenotypes reported when expression levels of 
Bves are experimentally downregulated, there has been no definition of the 
molecular mechanism behind these phenotypes.  While the data presented here 
do not address the molecular mechanism behind these phenotypes, a depression 
in Rac1/Cdc42 signaling could account for the previously reported experimental 
results.  
To this point, all reported mutant phenotypes that occur when levels of 
Bves are experimentally manipulated exhibit abnormalities consistent with 
defects in cellular movement and/or adhesion.  Rho-family GTPases have been 
demonstrated to be one nexus between coordination of cellular adhesion and 
adhesion (Evers et al. 2000; Noren et al. 2000; Teramoto et al. 2003; Noritake et 
al. 2005).  Rho-family GTPases have been shown to be necessary for cadherin-
based adhesion in multiple cell types (Braga et al. 1997; Hordijk et al. 1997; 
Kuroda et al. 1997; Kodama et al. 1999).  The control of cellular adhesion by 
Rho-family GTPases has been shown to be direct, and not merely a by-product 
of GTPase control of actin-based motility.  IQGAP, a downstream target of 
GTPase signaling, negatively regulates cell-cell adhesion by interacting with ß-
catenin, which causes α-catenin to dissociate from the cadherin-catenin complex 
(Kuroda et al. 1998; Fukata et al. 1999).  Thus, phenotypes that indicate 
disruption of cell motility and/or cell adhesion are entirely consistent with defects 
in Rho-family GTPase signaling. 
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 Brand and colleagues reported a delay in skeletal muscle regeneration 
when Bves is globally inactivated in the mouse through gene targeting (Andree et 
al. 2002).  Interestingly, it has been recently reported that GEFT is a potent 
regulator of mesenchymal cell behavior during skeletal muscle regeneration in 
mammalian models (Bryan et al. 2005).  In this model, either control virus or 
GEFT virus was injected into the anterior tibialis muscle with cardiotoxin.  In this 
standard skeletal muscle regeneration assay, cardiotoxin kills mature skeletal 
muscle, and the resident mesenchymal satellite cells then proliferate and 
differentiate to regenerate muscle cells (Carlson 1973; Carlson and Faulkner 
1983).  Upon viral overexpression of GEFT, a powerful promotion of skeletal 
muscle regeneration was seen (Bryan et al. 2005).  Thus, Bves and GEFT, which 
I have shown here to be interacting proteins, have both been experimentally 
demonstrated to be involved in regulation of skeletal muscle regeneration. 
 Later, our laboratory presented data demonstrating that Bves plays a role 
in control of epithelial sheet integrity and in regulation of wound healing in vitro 
(Ripley et al. 2004).  When levels of expressed Bves are reduced by morpholino 
antisense oligonucleotides, a decrease in epithelial integrity of cultured corneal 
cells was observed.  Similar treatment of these cells in wound healing models 
induced an increase in cell movement at the wound surface but regeneration of 
an intact epithelium was ultimately impeded (Ripley et al. 2004).  Proper 
regulation of GTPases has been previously demonstrated to be critical for proper 
regulation of corneal epithelial wound healing (Kimura et al. 2006; Lee and Kay 
 98 
2006).  Again, our laboratory has reproduced an experimental result by 
perturbing Bves function that has also been reported to be a result of disruption 
of Rho-GTPase function.  This finding also further supports the hypothesis that 
Bves modulates Rho-GTPase activity. 
 Finally, our laboratory recently reported that experimental downregulation 
of Bves expression in developing Xenopus laevis results in major defects in 
movement of epithelial cells (Ripley et al. 2006).  When Bves knockdown is 
experimentally induced at the two-cell stage, gastrulation is arrested by disruption 
of epiboly and involution.  When a clonal knockdown of Bves is performed by 
injection of morpholino into the A1 blastomere, progenitors of this blastomere 
move completely randomly throughout the embryo and cell intercalation during 
gastrulation is abnormal (Ripley et al. 2006).  As before, this phenotype is highly 
consistent with other published phenotypes described when Rho-family GTPase 
signaling is perturbed.  Rac1 signaling has been demonstrated to be necessary 
for convergent extension movements and cell intercalation during gastrulation 
(Tahinci and Symes 2003), and Cdc42 has also been shown to be a regulator of 
gastrulation and convergent extension (Choi and Han 2002; Penzo-Mendez et al. 
2003).  These phenotypes are consistent with the Xenopus phenotype, and 
suggest a disruption in a common molecular pathway. 
 The alteration of cell motility upon transfection of Bves and truncated Bves 
presented in Chapter III also supports the hypothesis that Bves modulation of 
Rho-GTPase signaling may be responsible for the previously described 
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phenotypes.  In these experiments, overexpression of either full-length or 
truncated Bves reduced the ability of NIH 3T3 cells to migrate abnormally (Figure 
17).  Wound healing, skeletal muscle regeneration by satellite cells, and 
migration of cells during gastrulation of Xenopus laevis are all processes that 
require highly regulated cellular movement.  The knockdown experiments in cell 
culture and Xenopus models discussed above both demonstrate exhibit defective 
cell migration.  In the Bves -/- mouse model, the movement ability or speed of 
satellite cells was not measured, and it was not noted if motility of satellite cells 
appeared to be affected.     
 In summary, the interaction between Bves and a modulator of Rho-family 
GTPase signaling could represent a molecular explanation for previously 
observed phenotypes exerted by experimental manipulation of Bves expression 
levels.  While the data presented here demonstrate that Bves directly affects 
Rac1 and Cdc42 activity levels, experiments to determine whether alteration of 
Rac1 and Cdc42 activity occurs in the described mutant phenotypes have yet to 
be conducted.  Potential models of Bves modulation of these signaling cascades 
are discussed in Chapter III.  These models represent the first actual models for 
experimental testing that focus directly on one particular cellular pathway.  
Although many components of the Bves/Rho-family GTPase relationship remain 
to be defined, the importance of the discovery of an interaction between Bves 
and a characterized member of a known molecular pathway cannot be 
overstated.  Where investigators were previously left to investigate whole 
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organisms or whole cells upon manipulation, this interaction now provides a 
specific, characterized target for investigators to focus upon when evaluating 
experiments that manipulate Bves activity.    
 
Future Directions 
 In the final component of this thesis, potential future experiments and 
avenues of investigation will be presented.  By necessity, early examinations of 
Bves function have focused on “large-scale” assessment of experimental 
manipulation of Bves.  The product of the current work, however, represents a 
turning point in this field.  In the future, investigators will be able to focus on a 
particular cellular pathway when designing experiments and evaluating results.   
 First, further identification of interacting partners is necessary for a 
thorough explanation of Bves activity.  Pursuit of this avenue of investigation has 
already begun in our laboratory.  The interaction described in Chapter III is the 
result of a yeast two-hybrid screen I conducted.  Naturally, this screen generated 
many potential interacting proteins, several of which passed all false positive 
screens.  These proteins are shown in Table 4.  These proteins should also 
further analyzed, as I analyzed GEFT.  It is likely that interaction between one or 
more of these proteins can be biochemically verified, and may reveal important 
functional knowledge regarding Bves.  In addition to the yeast two-hybrid screen 
described here, I have performed a split-ubiquitin screen for Bves-interacting 
proteins.  The recently developed split-ubiquitin modification of the yeast two- 
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Table 4:  Summary of genes isolated from yeast two-hybrid screen against 
embryonic heart library.  Right column represents number of clones isolated in 
original screen. 
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hybrid system is superior for isolation of interacting partners of membrane-
associated and membrane-bound proteins (Fetchko and Stagljar 2004; Thaminy 
et al. 2004; Iyer et al. 2005).  Using this technology, I have isolated an interaction 
between Bves and Ndrg4 (N-myc regulated downstream gene 4) (Smith and 
Bader, unpublished results).  Ndrg4, like Bves, is highly expressed in developing 
neural tissues and cardiac muscle (Zhou et al. 2001).  Interestingly, Ndrg4 has 
been experimentally demonstrated to control MEK and ERK phosphorylation 
(Hongo et al. 2006).  MEK and ERK are also downstream targets of Rho-family 
GTPase signaling (Zugasti et al. 2001; Rul et al. 2002).  Taking into account the 
GEFT-Bves interaction, the interaction of Bves with another component of 
Rac1/Cdc42 signaling provides further support for our findings that Bves 
modulates Rac1/Cdc42 signaling.  Further investigation and characterization of 
the Ndrg4-Bves interaction, as well as interaction between Bves and other 
proteins will undoubtedly provide valuable data for those interested in the 
molecular mechanisms underlying Bves activity.  As with the previously 
described yeast two-hybrid screen, many results from the split-ubiquitin screen 
that passed all tests for false-positives were not further examined.  These 
proteins, shown in Table 5, should definitely be further studied for potentially 
important interactions with Bves. 
 Along with identification of additional interacting proteins, it will be 
important to determine whether Bves is capable of interactions with other 
members of the Dbl family of GEFs.  As shown in Chapter III, Bves interacts with  
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Table 5:  Summary of genes isolated from split-ubiquitin screen against adult 
mouse heart library.  All of these proteins were isolated from original screen, and 
tested for potential false positive interaction.  All clones passed false positive 
screening. 
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GEFT through a region of GEFT that contains the highly conserved DH domain.  
While the Bves-Geft interaction may be an interaction unique to this member of 
the Dbl family, the possibility exists that this interaction is shared with other family 
members.  If Bves were found to interact with other GEFs, it would indicate that 
Bves might have a broad function in control of GTPase signaling, as opposed to 
the rather specific function of interaction with one particular GEF.  In fact, careful 
consideration of the PAK-21 pulldown assay of GTPase activation presented in 
Chapter III (Figure 16) indicates that Bves may modulate GTPase signaling 
through modulation of more than one GEF.  As seen in Figure 16, the amount of 
Cdc42 activity in this assay is almost entirely abolished by transfection of 
truncated Bves, and the amount of Rac1 activity is reduced by more than 50%.  
As more than one GEF is likely involved simultaneously in GTPase signaling in 
most cell types (Overbeck et al. 1995), the amount of activity reduction seen 
indicates that truncated Bves may be affecting the activity of more than one GEF 
at a time.  Thus, it is critical to determine whether Bves interacts promiscuously 
with multiple members of the Dbl GEF family, or is specific to GEFT, in order to 
truly elucidate the molecular mechanism underlying Bves control of GTPase 
signaling. 
 Potential roles for the other members of the Popdc gene family should 
also be studied to determine any role in regulation of GTPase signaling during 
cell movement and developmental processes.  As there is a very high degree of 
conservation between all family members in the intracellular carboxyl-terminus, 
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shown here to be important for interaction with GEFT, it is reasonable to 
hypothesize that some or all other Popdc family members may interact with 
GEFT or other GEFs.  At this point, no function has been ascribed to any of the 
other Popdc family members (Osler et al. 2006).  Additionally, functional 
redundancy seems to be indicated by the lack of a strong phenotype in Bves -/- 
mice.  All or some members of the Popdc family may interact with GEFs to 
regulate myriad cellular processes by affecting the activity states of GTPases.  
Alternatively, it has been shown that homophillic Bves protein-protein interaction 
occurs (Knight et al. 2003), therefore it is also possible that Bves is capable of 
interacting with other Popdc family members.  If this were the case, other Popdc 
family members may interact with and regulate the activity of Bves, thereby 
indirectly controlling GTPase activity.  In any case, it is clear that the relationship 
between Bves and other Popdc family members needs to be examined more 
closely, as well as the individual and perhaps unique characteristics of each 
family member.     
 Next, experimental definition of Rac1/Cdc42 activity levels in the 
knockdown/knockout phenotypes previously reported is necessary.  Examination 
of Rac1/Cdc42 levels in the satellite cells that regenerate skeletal muscle in the 
Bves-/- mouse (Andree et al. 2002) and comparison of these levels to that of a 
wildtype animal would strongly indicate that the observed phenotype is a direct 
result of disruption of proper Rac1/Cdc42 signaling induced by Bves inactivation.  
Similarly, determination of relative Rac1/Cdc42 activation states in the Xenopus 
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laevis model system utilized by our laboratory is necessary for similar reasons.  
Further investigation of these models, as well as the NIH 3T3 model system 
described in Chapter III, will also allow investigators to directly address the 
models presented above.  In these systems, definition of the subcellular 
localization of Bves, Rac1, Cdc42, and GEFT and potentially other GEFs is 
possible.  If experimental manipulation of Bves were found to alter the 
localization of other components of the Rho-family GTPase signaling pathway, 
this would strongly indicate that Bves is critical for proper localization of proteins 
involved in this pathway.  A variety of methods to address the localization of 
these proteins are available, but the most likely to be used involve usage of the 
immunoreagents described in Chapter II.  Additionally, now that these reagents 
are available for use, and have been demonstrated to be specific for the Bves 
protein, re-examination of previously published experiments should be 
performed.  For example, the visualized ultrastructural localization of Bves should 
be compared with the previously published electron micrographs that used the 
B846 polyclonal antisera (Osler et al. 2005).  As noted in Chapter II, the Bves 
protein has a wider localization when visualized with the SB panel of monoclonal 
antibodies than when visualized with the B846 antisera.   
 In summation, the work presented in this thesis represent not only a 
significant advance for the field of Bves study, but provide critical direction and 
tools for investigation to continue and advance.  The immunoreagents described 
in Chapter II not only helped to resolve long-standing discrepancies in the 
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literature, but also provide tools that will be used in the future.  These antibodies 
will undoubtedly be used to determine the subcellular localization of Bves in the 
future experiments described above, and also will provide valuable tools for 
immunoprecipitation-based experimental protocols necessary for investigation of 
new Bves-interacting proteins.  Furthermore, the identification of the first protein 
known to directly interact with Bves not only places Bves into a molecular 
context, but also provides focus and direction for future experiments investigating 
the function of Bves in modulation of Rho-family GTPase signaling.  Additionally, 
the screens for interating proteins that were performed as a part of this research 
have also isolated many other candidate proteins that interact with Bves in a 
genetic screen.  These interacting proteins may open more new and exciting 
avenues of investigation of the Bves protein, just as the identification of a direct 
interaction between Bves and Geft does in this work. 
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